KR20120014766A - Tannic acid-degradable laccase 3 of cryphonectria parasitica and usage thereof - Google Patents
Tannic acid-degradable laccase 3 of cryphonectria parasitica and usage thereof Download PDFInfo
- Publication number
- KR20120014766A KR20120014766A KR1020100076936A KR20100076936A KR20120014766A KR 20120014766 A KR20120014766 A KR 20120014766A KR 1020100076936 A KR1020100076936 A KR 1020100076936A KR 20100076936 A KR20100076936 A KR 20100076936A KR 20120014766 A KR20120014766 A KR 20120014766A
- Authority
- KR
- South Korea
- Prior art keywords
- laccase
- lacase
- expression vector
- recombinant expression
- culture
- Prior art date
Links
- 101710205163 Laccase-3 Proteins 0.000 title claims abstract description 45
- 241000221756 Cryphonectria parasitica Species 0.000 title claims abstract description 12
- 238000000034 method Methods 0.000 claims abstract description 32
- TUSDEZXZIZRFGC-UHFFFAOYSA-N 1-O-galloyl-3,6-(R)-HHDP-beta-D-glucose Natural products OC1C(O2)COC(=O)C3=CC(O)=C(O)C(O)=C3C3=C(O)C(O)=C(O)C=C3C(=O)OC1C(O)C2OC(=O)C1=CC(O)=C(O)C(O)=C1 TUSDEZXZIZRFGC-UHFFFAOYSA-N 0.000 claims abstract description 30
- 239000001263 FEMA 3042 Substances 0.000 claims abstract description 30
- LRBQNJMCXXYXIU-PPKXGCFTSA-N Penta-digallate-beta-D-glucose Natural products OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-PPKXGCFTSA-N 0.000 claims abstract description 30
- 229920002258 tannic acid Polymers 0.000 claims abstract description 30
- LRBQNJMCXXYXIU-NRMVVENXSA-N tannic acid Chemical compound OC1=C(O)C(O)=CC(C(=O)OC=2C(=C(O)C=C(C=2)C(=O)OC[C@@H]2[C@H]([C@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)[C@@H](OC(=O)C=3C=C(OC(=O)C=4C=C(O)C(O)=C(O)C=4)C(O)=C(O)C=3)O2)OC(=O)C=2C=C(OC(=O)C=3C=C(O)C(O)=C(O)C=3)C(O)=C(O)C=2)O)=C1 LRBQNJMCXXYXIU-NRMVVENXSA-N 0.000 claims abstract description 30
- 229940033123 tannic acid Drugs 0.000 claims abstract description 30
- 235000015523 tannic acid Nutrition 0.000 claims abstract description 30
- 239000013604 expression vector Substances 0.000 claims abstract description 29
- 238000003259 recombinant expression Methods 0.000 claims abstract description 25
- 230000001939 inductive effect Effects 0.000 claims abstract description 12
- 102100037777 Galactokinase Human genes 0.000 claims abstract description 11
- 150000001413 amino acids Chemical class 0.000 claims abstract description 11
- 101001066237 Treponema pallidum (strain Nichols) Putative galactokinase Proteins 0.000 claims abstract description 10
- 235000013305 food Nutrition 0.000 claims abstract description 7
- 101150094690 GAL1 gene Proteins 0.000 claims abstract 2
- 102100028501 Galanin peptides Human genes 0.000 claims abstract 2
- 101100121078 Homo sapiens GAL gene Proteins 0.000 claims abstract 2
- 240000004808 Saccharomyces cerevisiae Species 0.000 claims description 42
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 claims description 42
- 230000000694 effects Effects 0.000 claims description 42
- ISAKRJDGNUQOIC-UHFFFAOYSA-N Uracil Chemical compound O=C1C=CNC(=O)N1 ISAKRJDGNUQOIC-UHFFFAOYSA-N 0.000 claims description 24
- 108091026890 Coding region Proteins 0.000 claims description 16
- 102000004190 Enzymes Human genes 0.000 claims description 14
- 108090000790 Enzymes Proteins 0.000 claims description 14
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 claims description 12
- 229940035893 uracil Drugs 0.000 claims description 12
- 239000002253 acid Substances 0.000 claims description 9
- 238000004519 manufacturing process Methods 0.000 claims description 9
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 8
- 238000012258 culturing Methods 0.000 claims description 8
- 230000002950 deficient Effects 0.000 claims description 7
- 239000008121 dextrose Substances 0.000 claims description 7
- 239000000203 mixture Substances 0.000 claims description 7
- GFFGJBXGBJISGV-UHFFFAOYSA-N Adenine Chemical compound NC1=NC=NC2=C1N=CN2 GFFGJBXGBJISGV-UHFFFAOYSA-N 0.000 claims description 6
- 229930024421 Adenine Natural products 0.000 claims description 6
- 241000235070 Saccharomyces Species 0.000 claims description 6
- 229960000643 adenine Drugs 0.000 claims description 6
- 238000003776 cleavage reaction Methods 0.000 claims description 6
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- 230000007017 scission Effects 0.000 claims description 6
- 238000002845 discoloration Methods 0.000 claims description 5
- FDZZZRQASAIRJF-UHFFFAOYSA-M malachite green Chemical group [Cl-].C1=CC(N(C)C)=CC=C1C(C=1C=CC=CC=1)=C1C=CC(=[N+](C)C)C=C1 FDZZZRQASAIRJF-UHFFFAOYSA-M 0.000 claims description 5
- 229940107698 malachite green Drugs 0.000 claims description 5
- 108010076504 Protein Sorting Signals Proteins 0.000 claims description 4
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 claims description 4
- 230000015556 catabolic process Effects 0.000 claims description 4
- 238000006731 degradation reaction Methods 0.000 claims description 4
- 239000004382 Amylase Substances 0.000 claims description 3
- 108010065511 Amylases Proteins 0.000 claims description 3
- 102000013142 Amylases Human genes 0.000 claims description 3
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 claims description 3
- 240000007594 Oryza sativa Species 0.000 claims description 3
- 235000007164 Oryza sativa Nutrition 0.000 claims description 3
- 235000019418 amylase Nutrition 0.000 claims description 3
- 235000009566 rice Nutrition 0.000 claims description 3
- 239000002023 wood Substances 0.000 claims description 3
- IFGCUJZIWBUILZ-UHFFFAOYSA-N sodium 2-[[2-[[hydroxy-(3,4,5-trihydroxy-6-methyloxan-2-yl)oxyphosphoryl]amino]-4-methylpentanoyl]amino]-3-(1H-indol-3-yl)propanoic acid Chemical compound [Na+].C=1NC2=CC=CC=C2C=1CC(C(O)=O)NC(=O)C(CC(C)C)NP(O)(=O)OC1OC(C)C(O)C(O)C1O IFGCUJZIWBUILZ-UHFFFAOYSA-N 0.000 claims description 2
- 229920001864 tannin Polymers 0.000 claims description 2
- 235000018553 tannin Nutrition 0.000 claims description 2
- 239000001648 tannin Substances 0.000 claims description 2
- 230000000593 degrading effect Effects 0.000 claims 1
- 108010029541 Laccase Proteins 0.000 abstract description 46
- 230000001105 regulatory effect Effects 0.000 abstract description 7
- 239000000835 fiber Substances 0.000 abstract description 2
- 241000235088 Saccharomyces sp. Species 0.000 abstract 1
- 239000002609 medium Substances 0.000 description 41
- 210000004027 cell Anatomy 0.000 description 31
- 239000013612 plasmid Substances 0.000 description 22
- 108090000623 proteins and genes Proteins 0.000 description 19
- 239000012228 culture supernatant Substances 0.000 description 16
- 102000004169 proteins and genes Human genes 0.000 description 13
- 229940088598 enzyme Drugs 0.000 description 12
- 108020004414 DNA Proteins 0.000 description 10
- 239000000758 substrate Substances 0.000 description 10
- 239000000975 dye Substances 0.000 description 7
- 102000006602 glyceraldehyde-3-phosphate dehydrogenase Human genes 0.000 description 7
- 108020004445 glyceraldehyde-3-phosphate dehydrogenase Proteins 0.000 description 7
- 239000013598 vector Substances 0.000 description 7
- 150000002989 phenols Chemical class 0.000 description 6
- 108090000765 processed proteins & peptides Proteins 0.000 description 6
- 238000010186 staining Methods 0.000 description 6
- 241000196324 Embryophyta Species 0.000 description 5
- 230000010261 cell growth Effects 0.000 description 5
- 230000012010 growth Effects 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 230000028327 secretion Effects 0.000 description 5
- 239000006228 supernatant Substances 0.000 description 5
- 230000009466 transformation Effects 0.000 description 5
- 241000588724 Escherichia coli Species 0.000 description 4
- 102100039555 Galectin-7 Human genes 0.000 description 4
- 101000608772 Homo sapiens Galectin-7 Proteins 0.000 description 4
- 101150081322 LAC3 gene Proteins 0.000 description 4
- 108091005804 Peptidases Proteins 0.000 description 4
- 101100020526 Pycnoporus cinnabarinus LCC3-1 gene Proteins 0.000 description 4
- 238000004061 bleaching Methods 0.000 description 4
- 229940042399 direct acting antivirals protease inhibitors Drugs 0.000 description 4
- 230000006698 induction Effects 0.000 description 4
- 239000000137 peptide hydrolase inhibitor Substances 0.000 description 4
- 102000004196 processed proteins & peptides Human genes 0.000 description 4
- 239000006152 selective media Substances 0.000 description 4
- 239000000243 solution Substances 0.000 description 4
- 238000001262 western blot Methods 0.000 description 4
- 241000233866 Fungi Species 0.000 description 3
- 101150009006 HIS3 gene Proteins 0.000 description 3
- 102000035195 Peptidases Human genes 0.000 description 3
- 239000004365 Protease Substances 0.000 description 3
- 101100394989 Rhodopseudomonas palustris (strain ATCC BAA-98 / CGA009) hisI gene Proteins 0.000 description 3
- 108010087924 alanylproline Proteins 0.000 description 3
- 238000004458 analytical method Methods 0.000 description 3
- 210000000170 cell membrane Anatomy 0.000 description 3
- 230000002255 enzymatic effect Effects 0.000 description 3
- 229930182830 galactose Natural products 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 239000004922 lacquer Substances 0.000 description 3
- 229920005610 lignin Polymers 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 230000003278 mimic effect Effects 0.000 description 3
- 150000007523 nucleic acids Chemical group 0.000 description 3
- 229950000964 pepstatin Drugs 0.000 description 3
- 108010091212 pepstatin Proteins 0.000 description 3
- FAXGPCHRFPCXOO-LXTPJMTPSA-N pepstatin A Chemical compound OC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C)NC(=O)C[C@H](O)[C@H](CC(C)C)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C(C)C)NC(=O)CC(C)C FAXGPCHRFPCXOO-LXTPJMTPSA-N 0.000 description 3
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N phenol group Chemical group C1(=CC=CC=C1)O ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 3
- YBYRMVIVWMBXKQ-UHFFFAOYSA-N phenylmethanesulfonyl fluoride Chemical compound FS(=O)(=O)CC1=CC=CC=C1 YBYRMVIVWMBXKQ-UHFFFAOYSA-N 0.000 description 3
- 229920001184 polypeptide Polymers 0.000 description 3
- 108091008146 restriction endonucleases Proteins 0.000 description 3
- 230000003248 secreting effect Effects 0.000 description 3
- 239000004753 textile Substances 0.000 description 3
- 229920001817 Agar Polymers 0.000 description 2
- NHCPCLJZRSIDHS-ZLUOBGJFSA-N Ala-Asp-Ala Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](C)C(O)=O NHCPCLJZRSIDHS-ZLUOBGJFSA-N 0.000 description 2
- 102000007698 Alcohol dehydrogenase Human genes 0.000 description 2
- 108010021809 Alcohol dehydrogenase Proteins 0.000 description 2
- 108010025188 Alcohol oxidase Proteins 0.000 description 2
- 108010039627 Aprotinin Proteins 0.000 description 2
- HNXWVVHIGTZTBO-LKXGYXEUSA-N Asn-Ser-Thr Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@@H](N)CC(N)=O HNXWVVHIGTZTBO-LKXGYXEUSA-N 0.000 description 2
- 101710110426 Aspartyl protease inhibitor Proteins 0.000 description 2
- 241000228212 Aspergillus Species 0.000 description 2
- JPVYNHNXODAKFH-UHFFFAOYSA-N Cu2+ Chemical compound [Cu+2] JPVYNHNXODAKFH-UHFFFAOYSA-N 0.000 description 2
- LTLYEAJONXGNFG-DCAQKATOSA-N E64 Chemical compound NC(=N)NCCCCNC(=O)[C@H](CC(C)C)NC(=O)[C@H]1O[C@@H]1C(O)=O LTLYEAJONXGNFG-DCAQKATOSA-N 0.000 description 2
- KCXVZYZYPLLWCC-UHFFFAOYSA-N EDTA Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(O)=O)CC(O)=O KCXVZYZYPLLWCC-UHFFFAOYSA-N 0.000 description 2
- 101150037782 GAL2 gene Proteins 0.000 description 2
- 102100021735 Galectin-2 Human genes 0.000 description 2
- 241000235058 Komagataella pastoris Species 0.000 description 2
- XOWMDXHFSBCAKQ-SRVKXCTJSA-N Leu-Ser-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CO)C(=O)N[C@H](C(O)=O)CC(C)C XOWMDXHFSBCAKQ-SRVKXCTJSA-N 0.000 description 2
- 101100494726 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) pep-4 gene Proteins 0.000 description 2
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 2
- 108091028043 Nucleic acid sequence Proteins 0.000 description 2
- XJDMUQCLVSCRSJ-VZFHVOOUSA-N Ser-Thr-Ala Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O XJDMUQCLVSCRSJ-VZFHVOOUSA-N 0.000 description 2
- 241000222354 Trametes Species 0.000 description 2
- 102000004357 Transferases Human genes 0.000 description 2
- 108090000992 Transferases Proteins 0.000 description 2
- 108700019146 Transgenes Proteins 0.000 description 2
- 241000223259 Trichoderma Species 0.000 description 2
- IXKSXJFAGXLQOQ-XISFHERQSA-N WHWLQLKPGQPMY Chemical compound C([C@@H](C(=O)N[C@@H](CC=1C2=CC=CC=C2NC=1)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC=1C=CC(O)=CC=1)C(O)=O)NC(=O)[C@@H](N)CC=1C2=CC=CC=C2NC=1)C1=CNC=N1 IXKSXJFAGXLQOQ-XISFHERQSA-N 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 108010047495 alanylglycine Proteins 0.000 description 2
- 102000004139 alpha-Amylases Human genes 0.000 description 2
- 108090000637 alpha-Amylases Proteins 0.000 description 2
- HXXFSFRBOHSIMQ-FPRJBGLDSA-N alpha-D-galactose 1-phosphate Chemical compound OC[C@H]1O[C@H](OP(O)(O)=O)[C@H](O)[C@@H](O)[C@H]1O HXXFSFRBOHSIMQ-FPRJBGLDSA-N 0.000 description 2
- 229940024171 alpha-amylase Drugs 0.000 description 2
- 229960004405 aprotinin Drugs 0.000 description 2
- 239000003696 aspartic proteinase inhibitor Substances 0.000 description 2
- QVGXLLKOCUKJST-UHFFFAOYSA-N atomic oxygen Chemical compound [O] QVGXLLKOCUKJST-UHFFFAOYSA-N 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- 229910001431 copper ion Inorganic materials 0.000 description 2
- 230000007423 decrease Effects 0.000 description 2
- 230000003247 decreasing effect Effects 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- -1 diphenols Chemical class 0.000 description 2
- 238000001962 electrophoresis Methods 0.000 description 2
- 238000000605 extraction Methods 0.000 description 2
- 239000012634 fragment Substances 0.000 description 2
- 230000002538 fungal effect Effects 0.000 description 2
- 230000002414 glycolytic effect Effects 0.000 description 2
- 238000011534 incubation Methods 0.000 description 2
- 239000000411 inducer Substances 0.000 description 2
- 239000003112 inhibitor Substances 0.000 description 2
- 230000005764 inhibitory process Effects 0.000 description 2
- ZPNFWUPYTFPOJU-LPYSRVMUSA-N iniprol Chemical compound C([C@H]1C(=O)NCC(=O)NCC(=O)N[C@H]2CSSC[C@H]3C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@H](C(N[C@H](C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC=4C=CC=CC=4)C(=O)N[C@@H](CC=4C=CC(O)=CC=4)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CCCCN)C(=O)N[C@@H](C)C(=O)NCC(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCCCN)NC(=O)[C@H](CC=4C=CC=CC=4)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CCCCN)NC(=O)[C@H](C)NC(=O)[C@H](CCCNC(N)=N)NC2=O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CSSC[C@H](NC(=O)[C@H](CC=2C=CC=CC=2)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H]2N(CCC2)C(=O)[C@@H](N)CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N2[C@@H](CCC2)C(=O)N2[C@@H](CCC2)C(=O)N[C@@H](CC=2C=CC(O)=CC=2)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(=O)N2[C@@H](CCC2)C(=O)N3)C(=O)NCC(=O)NCC(=O)N[C@@H](C)C(O)=O)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@H](C(=O)N[C@@H](CC=2C=CC=CC=2)C(=O)N[C@H](C(=O)N1)C(C)C)[C@@H](C)O)[C@@H](C)CC)=O)[C@@H](C)CC)C1=CC=C(O)C=C1 ZPNFWUPYTFPOJU-LPYSRVMUSA-N 0.000 description 2
- 239000002054 inoculum Substances 0.000 description 2
- XIXADJRWDQXREU-UHFFFAOYSA-M lithium acetate Chemical compound [Li+].CC([O-])=O XIXADJRWDQXREU-UHFFFAOYSA-M 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 230000003647 oxidation Effects 0.000 description 2
- 238000007254 oxidation reaction Methods 0.000 description 2
- 229910052760 oxygen Inorganic materials 0.000 description 2
- 239000001301 oxygen Substances 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- 239000000049 pigment Substances 0.000 description 2
- 230000008569 process Effects 0.000 description 2
- 230000009257 reactivity Effects 0.000 description 2
- FGDZQCVHDSGLHJ-UHFFFAOYSA-M rubidium chloride Chemical compound [Cl-].[Rb+] FGDZQCVHDSGLHJ-UHFFFAOYSA-M 0.000 description 2
- 238000013518 transcription Methods 0.000 description 2
- 230000035897 transcription Effects 0.000 description 2
- 108010038745 tryptophylglycine Proteins 0.000 description 2
- 239000002351 wastewater Substances 0.000 description 2
- BRPMXFSTKXXNHF-IUCAKERBSA-N (2s)-1-[2-[[(2s)-pyrrolidine-2-carbonyl]amino]acetyl]pyrrolidine-2-carboxylic acid Chemical compound OC(=O)[C@@H]1CCCN1C(=O)CNC(=O)[C@H]1NCCC1 BRPMXFSTKXXNHF-IUCAKERBSA-N 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-M (E)-Ferulic acid Natural products COC1=CC(\C=C\C([O-])=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-M 0.000 description 1
- NHBKXEKEPDILRR-UHFFFAOYSA-N 2,3-bis(butanoylsulfanyl)propyl butanoate Chemical compound CCCC(=O)OCC(SC(=O)CCC)CSC(=O)CCC NHBKXEKEPDILRR-UHFFFAOYSA-N 0.000 description 1
- 101150090724 3 gene Proteins 0.000 description 1
- RBTBFTRPCNLSDE-UHFFFAOYSA-N 3,7-bis(dimethylamino)phenothiazin-5-ium Chemical compound C1=CC(N(C)C)=CC2=[S+]C3=CC(N(C)C)=CC=C3N=C21 RBTBFTRPCNLSDE-UHFFFAOYSA-N 0.000 description 1
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
- AAQGRPOPTAUUBM-ZLUOBGJFSA-N Ala-Ala-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O AAQGRPOPTAUUBM-ZLUOBGJFSA-N 0.000 description 1
- YYSWCHMLFJLLBJ-ZLUOBGJFSA-N Ala-Ala-Ser Chemical compound C[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O YYSWCHMLFJLLBJ-ZLUOBGJFSA-N 0.000 description 1
- XQGIRPGAVLFKBJ-CIUDSAMLSA-N Ala-Asn-Lys Chemical compound N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCCCN)C(=O)O XQGIRPGAVLFKBJ-CIUDSAMLSA-N 0.000 description 1
- ZIWWTZWAKYBUOB-CIUDSAMLSA-N Ala-Asp-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(O)=O ZIWWTZWAKYBUOB-CIUDSAMLSA-N 0.000 description 1
- BTYTYHBSJKQBQA-GCJQMDKQSA-N Ala-Asp-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](C)N)O BTYTYHBSJKQBQA-GCJQMDKQSA-N 0.000 description 1
- OILNWMNBLIHXQK-ZLUOBGJFSA-N Ala-Cys-Ser Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CS)C(=O)N[C@@H](CO)C(O)=O OILNWMNBLIHXQK-ZLUOBGJFSA-N 0.000 description 1
- BLGHHPHXVJWCNK-GUBZILKMSA-N Ala-Gln-Leu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(O)=O BLGHHPHXVJWCNK-GUBZILKMSA-N 0.000 description 1
- VGPWRRFOPXVGOH-BYPYZUCNSA-N Ala-Gly-Gly Chemical compound C[C@H](N)C(=O)NCC(=O)NCC(O)=O VGPWRRFOPXVGOH-BYPYZUCNSA-N 0.000 description 1
- CFPQUJZTLUQUTJ-HTFCKZLJSA-N Ala-Ile-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H]([C@@H](C)CC)NC(=O)[C@H](C)N CFPQUJZTLUQUTJ-HTFCKZLJSA-N 0.000 description 1
- OKIKVSXTXVVFDV-MMWGEVLESA-N Ala-Ile-Pro Chemical compound CC[C@H](C)[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](C)N OKIKVSXTXVVFDV-MMWGEVLESA-N 0.000 description 1
- SUMYEVXWCAYLLJ-GUBZILKMSA-N Ala-Leu-Gln Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(N)=O)C(O)=O SUMYEVXWCAYLLJ-GUBZILKMSA-N 0.000 description 1
- HOVPGJUNRLMIOZ-CIUDSAMLSA-N Ala-Ser-Leu Chemical compound CC(C)C[C@@H](C(O)=O)NC(=O)[C@H](CO)NC(=O)[C@H](C)N HOVPGJUNRLMIOZ-CIUDSAMLSA-N 0.000 description 1
- XSLGWYYNOSUMRM-ZKWXMUAHSA-N Ala-Val-Asn Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O XSLGWYYNOSUMRM-ZKWXMUAHSA-N 0.000 description 1
- ZCUFMRIQCPNOHZ-NRPADANISA-N Ala-Val-Gln Chemical compound C[C@@H](C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N ZCUFMRIQCPNOHZ-NRPADANISA-N 0.000 description 1
- YJHKTAMKPGFJCT-NRPADANISA-N Ala-Val-Glu Chemical compound [H]N[C@@H](C)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CCC(O)=O)C(O)=O YJHKTAMKPGFJCT-NRPADANISA-N 0.000 description 1
- PEFFAAKJGBZBKL-NAKRPEOUSA-N Arg-Ala-Ile Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O PEFFAAKJGBZBKL-NAKRPEOUSA-N 0.000 description 1
- SBVJJNJLFWSJOV-UBHSHLNASA-N Arg-Ala-Phe Chemical compound NC(=N)NCCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 SBVJJNJLFWSJOV-UBHSHLNASA-N 0.000 description 1
- VXXHDZKEQNGXNU-QXEWZRGKSA-N Arg-Asp-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCCN=C(N)N VXXHDZKEQNGXNU-QXEWZRGKSA-N 0.000 description 1
- SNBHMYQRNCJSOJ-CIUDSAMLSA-N Arg-Gln-Asn Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O SNBHMYQRNCJSOJ-CIUDSAMLSA-N 0.000 description 1
- JAYIQMNQDMOBFY-KKUMJFAQSA-N Arg-Glu-Tyr Chemical compound [H]N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O JAYIQMNQDMOBFY-KKUMJFAQSA-N 0.000 description 1
- QMQZYILAWUOLPV-JYJNAYRXSA-N Arg-Tyr-Arg Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CCCN=C(N)N)C(O)=O)CC1=CC=C(O)C=C1 QMQZYILAWUOLPV-JYJNAYRXSA-N 0.000 description 1
- AOJYORNRFWWEIV-IHRRRGAJSA-N Arg-Tyr-Asp Chemical compound NC(N)=NCCC[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](CC(O)=O)C(O)=O)CC1=CC=C(O)C=C1 AOJYORNRFWWEIV-IHRRRGAJSA-N 0.000 description 1
- XSGBIBGAMKTHMY-WHFBIAKZSA-N Asn-Asp-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(=O)NCC(O)=O XSGBIBGAMKTHMY-WHFBIAKZSA-N 0.000 description 1
- PAXHINASXXXILC-SRVKXCTJSA-N Asn-Asp-Tyr Chemical compound C1=CC(=CC=C1C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)O)NC(=O)[C@H](CC(=O)N)N)O PAXHINASXXXILC-SRVKXCTJSA-N 0.000 description 1
- NVWJMQNYLYWVNQ-BYULHYEWSA-N Asn-Ile-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(=O)NCC(O)=O NVWJMQNYLYWVNQ-BYULHYEWSA-N 0.000 description 1
- ACKNRKFVYUVWAC-ZPFDUUQYSA-N Asn-Ile-Lys Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CCCCN)C(=O)O)NC(=O)[C@H](CC(=O)N)N ACKNRKFVYUVWAC-ZPFDUUQYSA-N 0.000 description 1
- NCFJQJRLQJEECD-NHCYSSNCSA-N Asn-Leu-Val Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C(C)C)C(O)=O NCFJQJRLQJEECD-NHCYSSNCSA-N 0.000 description 1
- CDGHMJJJHYKMPA-DLOVCJGASA-N Asn-Phe-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@H](CC(=O)N)N CDGHMJJJHYKMPA-DLOVCJGASA-N 0.000 description 1
- YRTOMUMWSTUQAX-FXQIFTODSA-N Asn-Pro-Asp Chemical compound NC(=O)C[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC(O)=O)C(O)=O YRTOMUMWSTUQAX-FXQIFTODSA-N 0.000 description 1
- GKKUBLFXKRDMFC-BQBZGAKWSA-N Asn-Pro-Gly Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O GKKUBLFXKRDMFC-BQBZGAKWSA-N 0.000 description 1
- XTMZYFMTYJNABC-ZLUOBGJFSA-N Asn-Ser-Ala Chemical compound C[C@@H](C(=O)O)NC(=O)[C@H](CO)NC(=O)[C@H](CC(=O)N)N XTMZYFMTYJNABC-ZLUOBGJFSA-N 0.000 description 1
- WLVLIYYBPPONRJ-GCJQMDKQSA-N Asn-Thr-Ala Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(O)=O WLVLIYYBPPONRJ-GCJQMDKQSA-N 0.000 description 1
- XCBKBPRFACFFOO-AQZXSJQPSA-N Asn-Thr-Trp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC(=O)N)N)O XCBKBPRFACFFOO-AQZXSJQPSA-N 0.000 description 1
- CGYKCTPUGXFPMG-IHPCNDPISA-N Asn-Tyr-Trp Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O CGYKCTPUGXFPMG-IHPCNDPISA-N 0.000 description 1
- LRCIOEVFVGXZKB-BZSNNMDCSA-N Asn-Tyr-Tyr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O LRCIOEVFVGXZKB-BZSNNMDCSA-N 0.000 description 1
- XOQYDFCQPWAMSA-KKHAAJSZSA-N Asn-Val-Thr Chemical compound [H]N[C@@H](CC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O XOQYDFCQPWAMSA-KKHAAJSZSA-N 0.000 description 1
- QRULNKJGYQQZMW-ZLUOBGJFSA-N Asp-Asn-Asp Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O QRULNKJGYQQZMW-ZLUOBGJFSA-N 0.000 description 1
- VBVKSAFJPVXMFJ-CIUDSAMLSA-N Asp-Asn-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CC(=O)O)N VBVKSAFJPVXMFJ-CIUDSAMLSA-N 0.000 description 1
- JGDBHIVECJGXJA-FXQIFTODSA-N Asp-Asp-Arg Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(O)=O JGDBHIVECJGXJA-FXQIFTODSA-N 0.000 description 1
- VAWNQIGQPUOPQW-ACZMJKKPSA-N Asp-Glu-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(O)=O VAWNQIGQPUOPQW-ACZMJKKPSA-N 0.000 description 1
- ZEDBMCPXPIYJLW-XHNCKOQMSA-N Asp-Glu-Pro Chemical compound C1C[C@@H](N(C1)C(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC(=O)O)N)C(=O)O ZEDBMCPXPIYJLW-XHNCKOQMSA-N 0.000 description 1
- JUWZKMBALYLZCK-WHFBIAKZSA-N Asp-Gly-Asn Chemical compound OC(=O)C[C@H](N)C(=O)NCC(=O)N[C@@H](CC(N)=O)C(O)=O JUWZKMBALYLZCK-WHFBIAKZSA-N 0.000 description 1
- WSGVTKZFVJSJOG-RCOVLWMOSA-N Asp-Gly-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O WSGVTKZFVJSJOG-RCOVLWMOSA-N 0.000 description 1
- OGTCOKZFOJIZFG-CIUDSAMLSA-N Asp-His-Asp Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC(O)=O)C(O)=O OGTCOKZFOJIZFG-CIUDSAMLSA-N 0.000 description 1
- AYFVRYXNDHBECD-YUMQZZPRSA-N Asp-Leu-Gly Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC(C)C)C(=O)NCC(O)=O AYFVRYXNDHBECD-YUMQZZPRSA-N 0.000 description 1
- UMHUHHJMEXNSIV-CIUDSAMLSA-N Asp-Leu-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CC(O)=O UMHUHHJMEXNSIV-CIUDSAMLSA-N 0.000 description 1
- KOWYNSKRPUWSFG-IHPCNDPISA-N Asp-Phe-Trp Chemical compound C1=CC=C(C=C1)C[C@@H](C(=O)N[C@@H](CC2=CNC3=CC=CC=C32)C(=O)O)NC(=O)[C@H](CC(=O)O)N KOWYNSKRPUWSFG-IHPCNDPISA-N 0.000 description 1
- GPPIDDWYKJPRES-YDHLFZDLSA-N Asp-Phe-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](C(C)C)C(O)=O GPPIDDWYKJPRES-YDHLFZDLSA-N 0.000 description 1
- RVMXMLSYBTXCAV-VEVYYDQMSA-N Asp-Pro-Thr Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O RVMXMLSYBTXCAV-VEVYYDQMSA-N 0.000 description 1
- KGHLGJAXYSVNJP-WHFBIAKZSA-N Asp-Ser-Gly Chemical compound OC(=O)C[C@H](N)C(=O)N[C@@H](CO)C(=O)NCC(O)=O KGHLGJAXYSVNJP-WHFBIAKZSA-N 0.000 description 1
- XOASPVGNFAMYBD-WFBYXXMGSA-N Asp-Trp-Ala Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(=O)N[C@@H](C)C(O)=O XOASPVGNFAMYBD-WFBYXXMGSA-N 0.000 description 1
- ZUNMTUPRQMWMHX-LSJOCFKGSA-N Asp-Val-Val Chemical compound [H]N[C@@H](CC(O)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O ZUNMTUPRQMWMHX-LSJOCFKGSA-N 0.000 description 1
- 241000221198 Basidiomycota Species 0.000 description 1
- UXVMQQNJUSDDNG-UHFFFAOYSA-L Calcium chloride Chemical compound [Cl-].[Cl-].[Ca+2] UXVMQQNJUSDDNG-UHFFFAOYSA-L 0.000 description 1
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- CVLIHKBUPSFRQP-WHFBIAKZSA-N Cys-Gly-Ala Chemical compound [H]N[C@@H](CS)C(=O)NCC(=O)N[C@@H](C)C(O)=O CVLIHKBUPSFRQP-WHFBIAKZSA-N 0.000 description 1
- TXGDWPBLUFQODU-XGEHTFHBSA-N Cys-Pro-Thr Chemical compound [H]N[C@@H](CS)C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O TXGDWPBLUFQODU-XGEHTFHBSA-N 0.000 description 1
- 238000001712 DNA sequencing Methods 0.000 description 1
- 241000672609 Escherichia coli BL21 Species 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- WUAYFMZULZDSLB-ACZMJKKPSA-N Gln-Ala-Asn Chemical compound NC(=O)C[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H](N)CCC(N)=O WUAYFMZULZDSLB-ACZMJKKPSA-N 0.000 description 1
- OVQXQLWWJSNYFV-XEGUGMAKSA-N Gln-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@@H](NC(=O)[C@@H](N)CCC(N)=O)C)C(O)=O)=CNC2=C1 OVQXQLWWJSNYFV-XEGUGMAKSA-N 0.000 description 1
- LMPBBFWHCRURJD-LAEOZQHASA-N Gln-Asn-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](CCC(=O)N)N LMPBBFWHCRURJD-LAEOZQHASA-N 0.000 description 1
- KHGGWBRVRPHFMH-PEFMBERDSA-N Gln-Ile-Asn Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)[C@H](CCC(=O)N)N KHGGWBRVRPHFMH-PEFMBERDSA-N 0.000 description 1
- HYPVLWGNBIYTNA-GUBZILKMSA-N Gln-Leu-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](C)C(O)=O HYPVLWGNBIYTNA-GUBZILKMSA-N 0.000 description 1
- ZBKUIQNCRIYVGH-SDDRHHMPSA-N Gln-Leu-Pro Chemical compound CC(C)C[C@@H](C(=O)N1CCC[C@@H]1C(=O)O)NC(=O)[C@H](CCC(=O)N)N ZBKUIQNCRIYVGH-SDDRHHMPSA-N 0.000 description 1
- YPMDZWPZFOZYFG-GUBZILKMSA-N Gln-Leu-Ser Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CO)C(O)=O YPMDZWPZFOZYFG-GUBZILKMSA-N 0.000 description 1
- KUBFPYIMAGXGBT-ACZMJKKPSA-N Gln-Ser-Ala Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](C)C(O)=O KUBFPYIMAGXGBT-ACZMJKKPSA-N 0.000 description 1
- CSMHMEATMDCQNY-DZKIICNBSA-N Gln-Val-Tyr Chemical compound [H]N[C@@H](CCC(N)=O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O CSMHMEATMDCQNY-DZKIICNBSA-N 0.000 description 1
- FKGNJUCQKXQNRA-NRPADANISA-N Glu-Cys-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@H](CS)NC(=O)[C@@H](N)CCC(O)=O FKGNJUCQKXQNRA-NRPADANISA-N 0.000 description 1
- LRPXYSGPOBVBEH-IUCAKERBSA-N Glu-Gly-Leu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)NCC(=O)N[C@@H](CC(C)C)C(O)=O LRPXYSGPOBVBEH-IUCAKERBSA-N 0.000 description 1
- ITVBKCZZLJUUHI-HTUGSXCWSA-N Glu-Phe-Thr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(O)=O ITVBKCZZLJUUHI-HTUGSXCWSA-N 0.000 description 1
- ARIORLIIMJACKZ-KKUMJFAQSA-N Glu-Pro-Tyr Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(O)=O ARIORLIIMJACKZ-KKUMJFAQSA-N 0.000 description 1
- GMVCSRBOSIUTFC-FXQIFTODSA-N Glu-Ser-Glu Chemical compound [H]N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCC(O)=O)C(O)=O GMVCSRBOSIUTFC-FXQIFTODSA-N 0.000 description 1
- MIWJDJAMMKHUAR-ZVZYQTTQSA-N Glu-Trp-Val Chemical compound CC(C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CCC(=O)O)N MIWJDJAMMKHUAR-ZVZYQTTQSA-N 0.000 description 1
- WKJKBELXHCTHIJ-WPRPVWTQSA-N Gly-Arg-Val Chemical compound CC(C)[C@@H](C(O)=O)NC(=O)[C@@H](NC(=O)CN)CCCN=C(N)N WKJKBELXHCTHIJ-WPRPVWTQSA-N 0.000 description 1
- QGZSAHIZRQHCEQ-QWRGUYRKSA-N Gly-Asp-Tyr Chemical compound NCC(=O)N[C@@H](CC(O)=O)C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 QGZSAHIZRQHCEQ-QWRGUYRKSA-N 0.000 description 1
- QSVCIFZPGLOZGH-WDSKDSINSA-N Gly-Glu-Ser Chemical compound NCC(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CO)C(O)=O QSVCIFZPGLOZGH-WDSKDSINSA-N 0.000 description 1
- LRQXRHGQEVWGPV-NHCYSSNCSA-N Gly-Leu-Ile Chemical compound CC[C@H](C)[C@@H](C(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)CN LRQXRHGQEVWGPV-NHCYSSNCSA-N 0.000 description 1
- ICUTTWWCDIIIEE-BQBZGAKWSA-N Gly-Met-Asn Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)O)NC(=O)CN ICUTTWWCDIIIEE-BQBZGAKWSA-N 0.000 description 1
- GGLIDLCEPDHEJO-BQBZGAKWSA-N Gly-Pro-Ala Chemical compound OC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1C(=O)CN GGLIDLCEPDHEJO-BQBZGAKWSA-N 0.000 description 1
- VNNRLUNBJSWZPF-ZKWXMUAHSA-N Gly-Ser-Ile Chemical compound [H]NCC(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O VNNRLUNBJSWZPF-ZKWXMUAHSA-N 0.000 description 1
- WCORRBXVISTKQL-WHFBIAKZSA-N Gly-Ser-Ser Chemical compound NCC(=O)N[C@@H](CO)C(=O)N[C@@H](CO)C(O)=O WCORRBXVISTKQL-WHFBIAKZSA-N 0.000 description 1
- JQFILXICXLDTRR-FBCQKBJTSA-N Gly-Thr-Gly Chemical compound NCC(=O)N[C@@H]([C@H](O)C)C(=O)NCC(O)=O JQFILXICXLDTRR-FBCQKBJTSA-N 0.000 description 1
- 241000238631 Hexapoda Species 0.000 description 1
- AASLOGQZZKZWKH-SRVKXCTJSA-N His-Cys-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CS)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N AASLOGQZZKZWKH-SRVKXCTJSA-N 0.000 description 1
- VTMLJMNQHKBPON-QWRGUYRKSA-N His-Gly-His Chemical compound C([C@H](N)C(=O)NCC(=O)N[C@@H](CC=1NC=NC=1)C(O)=O)C1=CN=CN1 VTMLJMNQHKBPON-QWRGUYRKSA-N 0.000 description 1
- PGTISAJTWZPFGN-PEXQALLHSA-N His-Gly-Ile Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)NCC(=O)N[C@@H]([C@@H](C)CC)C(O)=O PGTISAJTWZPFGN-PEXQALLHSA-N 0.000 description 1
- 108010093488 His-His-His-His-His-His Proteins 0.000 description 1
- ZFDKSLBEWYCOCS-BZSNNMDCSA-N His-Phe-Lys Chemical compound C([C@@H](C(=O)N[C@@H](CCCCN)C(O)=O)NC(=O)[C@@H](N)CC=1NC=NC=1)C1=CC=CC=C1 ZFDKSLBEWYCOCS-BZSNNMDCSA-N 0.000 description 1
- DGLAHESNTJWGDO-SRVKXCTJSA-N His-Ser-His Chemical compound C1=C(NC=N1)C[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CC2=CN=CN2)C(=O)O)N DGLAHESNTJWGDO-SRVKXCTJSA-N 0.000 description 1
- UWSMZKRTOZEGDD-CUJWVEQBSA-N His-Thr-Ser Chemical compound [H]N[C@@H](CC1=CNC=N1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CO)C(O)=O UWSMZKRTOZEGDD-CUJWVEQBSA-N 0.000 description 1
- 101001024874 Homo sapiens Galactokinase Proteins 0.000 description 1
- DPTBVFUDCPINIP-JURCDPSOSA-N Ile-Ala-Phe Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC1=CC=CC=C1 DPTBVFUDCPINIP-JURCDPSOSA-N 0.000 description 1
- HDOYNXLPTRQLAD-JBDRJPRFSA-N Ile-Ala-Ser Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(=O)O)N HDOYNXLPTRQLAD-JBDRJPRFSA-N 0.000 description 1
- WZPIKDWQVRTATP-SYWGBEHUSA-N Ile-Ala-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](C)NC(=O)[C@@H](N)[C@@H](C)CC)C(O)=O)=CNC2=C1 WZPIKDWQVRTATP-SYWGBEHUSA-N 0.000 description 1
- SCHZQZPYHBWYEQ-PEFMBERDSA-N Ile-Asn-Glu Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](CC(=O)N)C(=O)N[C@@H](CCC(=O)O)C(=O)O)N SCHZQZPYHBWYEQ-PEFMBERDSA-N 0.000 description 1
- OVPYIUNCVSOVNF-ZPFDUUQYSA-N Ile-Gln-Pro Natural products CC[C@H](C)[C@H](N)C(=O)N[C@@H](CCC(N)=O)C(=O)N1CCC[C@H]1C(O)=O OVPYIUNCVSOVNF-ZPFDUUQYSA-N 0.000 description 1
- IGJWJGIHUFQANP-LAEOZQHASA-N Ile-Gly-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)NCC(=O)N[C@@H](CCC(=O)N)C(=O)O)N IGJWJGIHUFQANP-LAEOZQHASA-N 0.000 description 1
- CCYGNFBYUNHFSC-MGHWNKPDSA-N Ile-His-Phe Chemical compound [H]N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC1=CNC=N1)C(=O)N[C@@H](CC1=CC=CC=C1)C(O)=O CCYGNFBYUNHFSC-MGHWNKPDSA-N 0.000 description 1
- YCKPUHHMCFSUMD-IUKAMOBKSA-N Ile-Thr-Asp Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(=O)O)C(=O)O)N YCKPUHHMCFSUMD-IUKAMOBKSA-N 0.000 description 1
- NAFIFZNBSPWYOO-RWRJDSDZSA-N Ile-Thr-Gln Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCC(=O)N)C(=O)O)N NAFIFZNBSPWYOO-RWRJDSDZSA-N 0.000 description 1
- BCISUQVFDGYZBO-QSFUFRPTSA-N Ile-Val-Asp Chemical compound CC[C@H](C)[C@H](N)C(=O)N[C@@H](C(C)C)C(=O)N[C@H](C(O)=O)CC(O)=O BCISUQVFDGYZBO-QSFUFRPTSA-N 0.000 description 1
- 102000004195 Isomerases Human genes 0.000 description 1
- 108090000769 Isomerases Proteins 0.000 description 1
- 101710096444 Killer toxin Proteins 0.000 description 1
- UGTHTQWIQKEDEH-BQBZGAKWSA-N L-alanyl-L-prolylglycine zwitterion Chemical compound C[C@H](N)C(=O)N1CCC[C@H]1C(=O)NCC(O)=O UGTHTQWIQKEDEH-BQBZGAKWSA-N 0.000 description 1
- SENJXOPIZNYLHU-UHFFFAOYSA-N L-leucyl-L-arginine Natural products CC(C)CC(N)C(=O)NC(C(O)=O)CCCN=C(N)N SENJXOPIZNYLHU-UHFFFAOYSA-N 0.000 description 1
- QUAAUWNLWMLERT-IHRRRGAJSA-N Leu-Arg-Leu Chemical compound CC(C)C[C@H](N)C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CC(C)C)C(O)=O QUAAUWNLWMLERT-IHRRRGAJSA-N 0.000 description 1
- HFBCHNRFRYLZNV-GUBZILKMSA-N Leu-Glu-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CC(O)=O)C(O)=O HFBCHNRFRYLZNV-GUBZILKMSA-N 0.000 description 1
- OXRLYTYUXAQTHP-YUMQZZPRSA-N Leu-Gly-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)NCC(=O)N[C@@H](C)C(O)=O OXRLYTYUXAQTHP-YUMQZZPRSA-N 0.000 description 1
- KOSWSHVQIVTVQF-ZPFDUUQYSA-N Leu-Ile-Asp Chemical compound [H]N[C@@H](CC(C)C)C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CC(O)=O)C(O)=O KOSWSHVQIVTVQF-ZPFDUUQYSA-N 0.000 description 1
- XVZCXCTYGHPNEM-UHFFFAOYSA-N Leu-Leu-Pro Natural products CC(C)CC(N)C(=O)NC(CC(C)C)C(=O)N1CCCC1C(O)=O XVZCXCTYGHPNEM-UHFFFAOYSA-N 0.000 description 1
- WMIOEVKKYIMVKI-DCAQKATOSA-N Leu-Pro-Ala Chemical compound [H]N[C@@H](CC(C)C)C(=O)N1CCC[C@H]1C(=O)N[C@@H](C)C(O)=O WMIOEVKKYIMVKI-DCAQKATOSA-N 0.000 description 1
- ZTPWXNOOKAXPPE-DCAQKATOSA-N Lys-Arg-Cys Chemical compound C(CCN)C[C@@H](C(=O)N[C@@H](CCCN=C(N)N)C(=O)N[C@@H](CS)C(=O)O)N ZTPWXNOOKAXPPE-DCAQKATOSA-N 0.000 description 1
- 108010052285 Membrane Proteins Proteins 0.000 description 1
- 102000018697 Membrane Proteins Human genes 0.000 description 1
- LMKSBGIUPVRHEH-FXQIFTODSA-N Met-Ala-Asn Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(N)=O LMKSBGIUPVRHEH-FXQIFTODSA-N 0.000 description 1
- QEVRUYFHWJJUHZ-DCAQKATOSA-N Met-Ala-Leu Chemical compound CSCC[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(C)C QEVRUYFHWJJUHZ-DCAQKATOSA-N 0.000 description 1
- MNNKPHGAPRUKMW-BPUTZDHNSA-N Met-Asp-Trp Chemical compound C1=CC=C2C(C[C@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@@H](N)CCSC)C(O)=O)=CNC2=C1 MNNKPHGAPRUKMW-BPUTZDHNSA-N 0.000 description 1
- MYKLINMAGAIRPJ-CIUDSAMLSA-N Met-Gln-Asn Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCC(N)=O)C(=O)N[C@@H](CC(N)=O)C(O)=O MYKLINMAGAIRPJ-CIUDSAMLSA-N 0.000 description 1
- OOSPRDCGTLQLBP-NHCYSSNCSA-N Met-Glu-Val Chemical compound [H]N[C@@H](CCSC)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C(C)C)C(O)=O OOSPRDCGTLQLBP-NHCYSSNCSA-N 0.000 description 1
- WWWGMQHQSAUXBU-BQBZGAKWSA-N Met-Gly-Asn Chemical compound CSCC[C@H](N)C(=O)NCC(=O)N[C@H](C(O)=O)CC(N)=O WWWGMQHQSAUXBU-BQBZGAKWSA-N 0.000 description 1
- BMHIFARYXOJDLD-WPRPVWTQSA-N Met-Gly-Val Chemical compound [H]N[C@@H](CCSC)C(=O)NCC(=O)N[C@@H](C(C)C)C(O)=O BMHIFARYXOJDLD-WPRPVWTQSA-N 0.000 description 1
- WRLYTJVPSUBYST-AVGNSLFASA-N Met-His-Met Chemical compound CSCC[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](CCSC)C(=O)O)N WRLYTJVPSUBYST-AVGNSLFASA-N 0.000 description 1
- 241000699670 Mus sp. Species 0.000 description 1
- AUEJLPRZGVVDNU-UHFFFAOYSA-N N-L-tyrosyl-L-leucine Natural products CC(C)CC(C(O)=O)NC(=O)C(N)CC1=CC=C(O)C=C1 AUEJLPRZGVVDNU-UHFFFAOYSA-N 0.000 description 1
- KZNQNBZMBZJQJO-UHFFFAOYSA-N N-glycyl-L-proline Natural products NCC(=O)N1CCCC1C(O)=O KZNQNBZMBZJQJO-UHFFFAOYSA-N 0.000 description 1
- 102000004316 Oxidoreductases Human genes 0.000 description 1
- 108090000854 Oxidoreductases Proteins 0.000 description 1
- 239000001888 Peptone Substances 0.000 description 1
- 108010080698 Peptones Proteins 0.000 description 1
- KIEPQOIQHFKQLK-PCBIJLKTSA-N Phe-Asn-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O KIEPQOIQHFKQLK-PCBIJLKTSA-N 0.000 description 1
- JHSRGEODDALISP-XVSYOHENSA-N Phe-Thr-Asn Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(O)=O JHSRGEODDALISP-XVSYOHENSA-N 0.000 description 1
- FGWUALWGCZJQDJ-URLPEUOOSA-N Phe-Thr-Ile Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O FGWUALWGCZJQDJ-URLPEUOOSA-N 0.000 description 1
- ZOGICTVLQDWPER-UFYCRDLUSA-N Phe-Tyr-Val Chemical compound [H]N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](C(C)C)C(O)=O ZOGICTVLQDWPER-UFYCRDLUSA-N 0.000 description 1
- 102000004160 Phosphoric Monoester Hydrolases Human genes 0.000 description 1
- 108090000608 Phosphoric Monoester Hydrolases Proteins 0.000 description 1
- 241000235648 Pichia Species 0.000 description 1
- XQLBWXHVZVBNJM-FXQIFTODSA-N Pro-Ala-Ser Chemical compound OC[C@@H](C(O)=O)NC(=O)[C@H](C)NC(=O)[C@@H]1CCCN1 XQLBWXHVZVBNJM-FXQIFTODSA-N 0.000 description 1
- SGCZFWSQERRKBD-BQBZGAKWSA-N Pro-Asp-Gly Chemical compound OC(=O)CNC(=O)[C@H](CC(O)=O)NC(=O)[C@@H]1CCCN1 SGCZFWSQERRKBD-BQBZGAKWSA-N 0.000 description 1
- BWCZJGJKOFUUCN-ZPFDUUQYSA-N Pro-Ile-Gln Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)CC)C(=O)N[C@@H](CCC(N)=O)C(O)=O BWCZJGJKOFUUCN-ZPFDUUQYSA-N 0.000 description 1
- SPLBRAKYXGOFSO-UNQGMJICSA-N Pro-Phe-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=CC=C1)NC(=O)[C@@H]2CCCN2)O SPLBRAKYXGOFSO-UNQGMJICSA-N 0.000 description 1
- RCYUBVHMVUHEBM-RCWTZXSCSA-N Pro-Pro-Thr Chemical compound [H]N1CCC[C@H]1C(=O)N1CCC[C@H]1C(=O)N[C@@H]([C@@H](C)O)C(O)=O RCYUBVHMVUHEBM-RCWTZXSCSA-N 0.000 description 1
- GMJDSFYVTAMIBF-FXQIFTODSA-N Pro-Ser-Asp Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O GMJDSFYVTAMIBF-FXQIFTODSA-N 0.000 description 1
- ITUDDXVFGFEKPD-NAKRPEOUSA-N Pro-Ser-Ile Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H]([C@@H](C)CC)C(O)=O ITUDDXVFGFEKPD-NAKRPEOUSA-N 0.000 description 1
- PRKWBYCXBBSLSK-GUBZILKMSA-N Pro-Ser-Val Chemical compound [H]N1CCC[C@H]1C(=O)N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(O)=O PRKWBYCXBBSLSK-GUBZILKMSA-N 0.000 description 1
- QKWYXRPICJEQAJ-KJEVXHAQSA-N Pro-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@@H]2CCCN2)O QKWYXRPICJEQAJ-KJEVXHAQSA-N 0.000 description 1
- 241000169446 Promethis Species 0.000 description 1
- 108010079005 RDV peptide Proteins 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 108020005091 Replication Origin Proteins 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- 241000235072 Saccharomyces bayanus Species 0.000 description 1
- 240000001900 Schleichera oleosa Species 0.000 description 1
- 235000010236 Schleichera oleosa Nutrition 0.000 description 1
- LVVBAKCGXXUHFO-ZLUOBGJFSA-N Ser-Ala-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(O)=O)C(O)=O LVVBAKCGXXUHFO-ZLUOBGJFSA-N 0.000 description 1
- JPIDMRXXNMIVKY-VZFHVOOUSA-N Ser-Ala-Thr Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C)C(=O)N[C@@H]([C@@H](C)O)C(O)=O JPIDMRXXNMIVKY-VZFHVOOUSA-N 0.000 description 1
- GRRAECZXRONTEE-UBHSHLNASA-N Ser-Cys-Trp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](CS)C(=O)N[C@@H](CC1=CNC2=C1C=CC=C2)C(O)=O GRRAECZXRONTEE-UBHSHLNASA-N 0.000 description 1
- SNVIOQXAHVORQM-WDSKDSINSA-N Ser-Gly-Gln Chemical compound [H]N[C@@H](CO)C(=O)NCC(=O)N[C@@H](CCC(N)=O)C(O)=O SNVIOQXAHVORQM-WDSKDSINSA-N 0.000 description 1
- TYIHBQYLIPJSIV-NYVOZVTQSA-N Ser-Trp-Trp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)N[C@@H](CC3=CNC4=CC=CC=C43)C(=O)O)NC(=O)[C@H](CO)N TYIHBQYLIPJSIV-NYVOZVTQSA-N 0.000 description 1
- UKKROEYWYIHWBD-ZKWXMUAHSA-N Ser-Val-Asp Chemical compound [H]N[C@@H](CO)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(O)=O)C(O)=O UKKROEYWYIHWBD-ZKWXMUAHSA-N 0.000 description 1
- IGROJMCBGRFRGI-YTLHQDLWSA-N Thr-Ala-Ala Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](C)C(O)=O IGROJMCBGRFRGI-YTLHQDLWSA-N 0.000 description 1
- DFTCYYILCSQGIZ-GCJQMDKQSA-N Thr-Ala-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(N)=O)C(O)=O DFTCYYILCSQGIZ-GCJQMDKQSA-N 0.000 description 1
- NJEMRSFGDNECGF-GCJQMDKQSA-N Thr-Ala-Asp Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@H](C(O)=O)CC(O)=O NJEMRSFGDNECGF-GCJQMDKQSA-N 0.000 description 1
- DWYAUVCQDTZIJI-VZFHVOOUSA-N Thr-Ala-Ser Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O DWYAUVCQDTZIJI-VZFHVOOUSA-N 0.000 description 1
- OJRNZRROAIAHDL-LKXGYXEUSA-N Thr-Asn-Ser Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CO)C(O)=O OJRNZRROAIAHDL-LKXGYXEUSA-N 0.000 description 1
- YUOCMLNTUZAGNF-KLHWPWHYSA-N Thr-His-Pro Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N2CCC[C@@H]2C(=O)O)N)O YUOCMLNTUZAGNF-KLHWPWHYSA-N 0.000 description 1
- XYFISNXATOERFZ-OSUNSFLBSA-N Thr-Ile-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H]([C@@H](C)O)N XYFISNXATOERFZ-OSUNSFLBSA-N 0.000 description 1
- XNTVWRJTUIOGQO-RHYQMDGZSA-N Thr-Met-Leu Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CCSC)C(=O)N[C@@H](CC(C)C)C(O)=O XNTVWRJTUIOGQO-RHYQMDGZSA-N 0.000 description 1
- WYLAVUAWOUVUCA-XVSYOHENSA-N Thr-Phe-Asp Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)N[C@@H](CC(O)=O)C(O)=O WYLAVUAWOUVUCA-XVSYOHENSA-N 0.000 description 1
- QJIODPFLAASXJC-JHYOHUSXSA-N Thr-Thr-Phe Chemical compound C[C@H]([C@@H](C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC1=CC=CC=C1)C(=O)O)N)O QJIODPFLAASXJC-JHYOHUSXSA-N 0.000 description 1
- COYHRQWNJDJCNA-NUJDXYNKSA-N Thr-Thr-Thr Chemical compound C[C@@H](O)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H]([C@@H](C)O)C(O)=O COYHRQWNJDJCNA-NUJDXYNKSA-N 0.000 description 1
- BKIOKSLLAAZYTC-KKHAAJSZSA-N Thr-Val-Asn Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC(N)=O)C(O)=O BKIOKSLLAAZYTC-KKHAAJSZSA-N 0.000 description 1
- VYVBSMCZNHOZGD-RCWTZXSCSA-N Thr-Val-Val Chemical compound [H]N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](C(C)C)C(O)=O VYVBSMCZNHOZGD-RCWTZXSCSA-N 0.000 description 1
- 241000208227 Toxicodendron vernicifluum Species 0.000 description 1
- 241000222355 Trametes versicolor Species 0.000 description 1
- BEWOXKJJMBKRQL-AAEUAGOBSA-N Trp-Gly-Asp Chemical compound C1=CC=C2C(=C1)C(=CN2)C[C@@H](C(=O)NCC(=O)N[C@@H](CC(=O)O)C(=O)O)N BEWOXKJJMBKRQL-AAEUAGOBSA-N 0.000 description 1
- WVHUFSCKCBQKJW-HKUYNNGSSA-N Trp-Gly-Tyr Chemical compound C([C@H](NC(=O)CNC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)N)C(O)=O)C1=CC=C(O)C=C1 WVHUFSCKCBQKJW-HKUYNNGSSA-N 0.000 description 1
- STKZKWFOKOCSLW-UMPQAUOISA-N Trp-Thr-Val Chemical compound C1=CC=C2C(C[C@H](N)C(=O)N[C@H](C(=O)N[C@@H](C(C)C)C(O)=O)[C@@H](C)O)=CNC2=C1 STKZKWFOKOCSLW-UMPQAUOISA-N 0.000 description 1
- YGKVNUAKYPGORG-AVGNSLFASA-N Tyr-Asp-Glu Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CC(O)=O)C(=O)N[C@@H](CCC(O)=O)C(O)=O YGKVNUAKYPGORG-AVGNSLFASA-N 0.000 description 1
- FMOSEWZYZPMJAL-KKUMJFAQSA-N Tyr-Glu-Met Chemical compound CSCC[C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)N FMOSEWZYZPMJAL-KKUMJFAQSA-N 0.000 description 1
- HIINQLBHPIQYHN-JTQLQIEISA-N Tyr-Gly-Gly Chemical compound OC(=O)CNC(=O)CNC(=O)[C@@H](N)CC1=CC=C(O)C=C1 HIINQLBHPIQYHN-JTQLQIEISA-N 0.000 description 1
- QAYSODICXVZUIA-WLTAIBSBSA-N Tyr-Gly-Thr Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)NCC(=O)N[C@@H]([C@@H](C)O)C(O)=O QAYSODICXVZUIA-WLTAIBSBSA-N 0.000 description 1
- GQVZBMROTPEPIF-SRVKXCTJSA-N Tyr-Ser-Asp Chemical compound [H]N[C@@H](CC1=CC=C(O)C=C1)C(=O)N[C@@H](CO)C(=O)N[C@@H](CC(O)=O)C(O)=O GQVZBMROTPEPIF-SRVKXCTJSA-N 0.000 description 1
- AKKYBQGHUAWPJR-MNSWYVGCSA-N Tyr-Thr-Trp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC1=CNC2=CC=CC=C21)C(=O)O)NC(=O)[C@H](CC3=CC=C(C=C3)O)N)O AKKYBQGHUAWPJR-MNSWYVGCSA-N 0.000 description 1
- KUXCBJFJURINGF-PXDAIIFMSA-N Tyr-Trp-Ile Chemical compound CC[C@H](C)[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](CC3=CC=C(C=C3)O)N KUXCBJFJURINGF-PXDAIIFMSA-N 0.000 description 1
- 102000003425 Tyrosinase Human genes 0.000 description 1
- 108060008724 Tyrosinase Proteins 0.000 description 1
- HSCJRCZFDFQWRP-RDKQLNKOSA-N UDP-D-glucose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)OC1OP(O)(=O)OP(O)(=O)OC[C@@H]1[C@@H](O)[C@@H](O)[C@H](N2C(NC(=O)C=C2)=O)O1 HSCJRCZFDFQWRP-RDKQLNKOSA-N 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- 108010064997 VPY tripeptide Proteins 0.000 description 1
- AZSHAZJLOZQYAY-FXQIFTODSA-N Val-Ala-Ser Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](C)C(=O)N[C@@H](CO)C(O)=O AZSHAZJLOZQYAY-FXQIFTODSA-N 0.000 description 1
- PVPAOIGJYHVWBT-KKHAAJSZSA-N Val-Asn-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC(=O)N)NC(=O)[C@H](C(C)C)N)O PVPAOIGJYHVWBT-KKHAAJSZSA-N 0.000 description 1
- YCMXFKWYJFZFKS-LAEOZQHASA-N Val-Gln-Asp Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)N)C(=O)N[C@@H](CC(=O)O)C(=O)O)N YCMXFKWYJFZFKS-LAEOZQHASA-N 0.000 description 1
- NYTKXWLZSNRILS-IFFSRLJSSA-N Val-Gln-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CCC(=O)N)NC(=O)[C@H](C(C)C)N)O NYTKXWLZSNRILS-IFFSRLJSSA-N 0.000 description 1
- BRPKEERLGYNCNC-NHCYSSNCSA-N Val-Glu-Arg Chemical compound CC(C)[C@H](N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@H](C(O)=O)CCCN=C(N)N BRPKEERLGYNCNC-NHCYSSNCSA-N 0.000 description 1
- ZXAGTABZUOMUDO-GVXVVHGQSA-N Val-Glu-Lys Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CCC(=O)O)C(=O)N[C@@H](CCCCN)C(=O)O)N ZXAGTABZUOMUDO-GVXVVHGQSA-N 0.000 description 1
- LAYSXAOGWHKNED-XPUUQOCRSA-N Val-Gly-Ser Chemical compound CC(C)[C@H](N)C(=O)NCC(=O)N[C@@H](CO)C(O)=O LAYSXAOGWHKNED-XPUUQOCRSA-N 0.000 description 1
- XBRMBDFYOFARST-AVGNSLFASA-N Val-His-Val Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CC1=CN=CN1)C(=O)N[C@@H](C(C)C)C(=O)O)N XBRMBDFYOFARST-AVGNSLFASA-N 0.000 description 1
- DJQIUOKSNRBTSV-CYDGBPFRSA-N Val-Ile-Val Chemical compound CC[C@H](C)[C@@H](C(=O)N[C@@H](C(C)C)C(=O)O)NC(=O)[C@H](C(C)C)N DJQIUOKSNRBTSV-CYDGBPFRSA-N 0.000 description 1
- YTNGABPUXFEOGU-SRVKXCTJSA-N Val-Pro-Arg Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@@H](CCCN=C(N)N)C(O)=O YTNGABPUXFEOGU-SRVKXCTJSA-N 0.000 description 1
- QWCZXKIFPWPQHR-JYJNAYRXSA-N Val-Pro-Tyr Chemical compound CC(C)[C@H](N)C(=O)N1CCC[C@H]1C(=O)N[C@H](C(O)=O)CC1=CC=C(O)C=C1 QWCZXKIFPWPQHR-JYJNAYRXSA-N 0.000 description 1
- DLLRRUDLMSJTMB-GUBZILKMSA-N Val-Ser-Met Chemical compound CC(C)[C@@H](C(=O)N[C@@H](CO)C(=O)N[C@@H](CCSC)C(=O)O)N DLLRRUDLMSJTMB-GUBZILKMSA-N 0.000 description 1
- DLRZGNXCXUGIDG-KKHAAJSZSA-N Val-Thr-Asp Chemical compound C[C@H]([C@@H](C(=O)N[C@@H](CC(=O)O)C(=O)O)NC(=O)[C@H](C(C)C)N)O DLRZGNXCXUGIDG-KKHAAJSZSA-N 0.000 description 1
- YQYFYUSYEDNLSD-YEPSODPASA-N Val-Thr-Gly Chemical compound CC(C)[C@H](N)C(=O)N[C@@H]([C@@H](C)O)C(=O)NCC(O)=O YQYFYUSYEDNLSD-YEPSODPASA-N 0.000 description 1
- ZLMFVXMJFIWIRE-FHWLQOOXSA-N Val-Trp-Leu Chemical compound CC(C)C[C@@H](C(=O)O)NC(=O)[C@H](CC1=CNC2=CC=CC=C21)NC(=O)[C@H](C(C)C)N ZLMFVXMJFIWIRE-FHWLQOOXSA-N 0.000 description 1
- BGTDGENDNWGMDQ-KJEVXHAQSA-N Val-Tyr-Thr Chemical compound C[C@H]([C@@H](C(=O)O)NC(=O)[C@H](CC1=CC=C(C=C1)O)NC(=O)[C@H](C(C)C)N)O BGTDGENDNWGMDQ-KJEVXHAQSA-N 0.000 description 1
- YVNQAIFQFWTPLQ-UHFFFAOYSA-O [4-[[4-(4-ethoxyanilino)phenyl]-[4-[ethyl-[(3-sulfophenyl)methyl]amino]-2-methylphenyl]methylidene]-3-methylcyclohexa-2,5-dien-1-ylidene]-ethyl-[(3-sulfophenyl)methyl]azanium Chemical compound C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C(=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=2C(=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S(O)(=O)=O)C)C=C1 YVNQAIFQFWTPLQ-UHFFFAOYSA-O 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 238000007792 addition Methods 0.000 description 1
- 239000002671 adjuvant Substances 0.000 description 1
- 238000001042 affinity chromatography Methods 0.000 description 1
- 108010076324 alanyl-glycyl-glycine Proteins 0.000 description 1
- 108010069020 alanyl-prolyl-glycine Proteins 0.000 description 1
- 108010086434 alanyl-seryl-glycine Proteins 0.000 description 1
- 108010041407 alanylaspartic acid Proteins 0.000 description 1
- 229930013930 alkaloid Natural products 0.000 description 1
- 108010050025 alpha-glutamyltryptophan Proteins 0.000 description 1
- 108010013835 arginine glutamate Proteins 0.000 description 1
- 108010084758 arginyl-tyrosyl-aspartic acid Proteins 0.000 description 1
- 150000004982 aromatic amines Chemical class 0.000 description 1
- 150000001491 aromatic compounds Chemical class 0.000 description 1
- 108010040443 aspartyl-aspartic acid Proteins 0.000 description 1
- 108010038633 aspartylglutamate Proteins 0.000 description 1
- 238000003556 assay Methods 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 235000021028 berry Nutrition 0.000 description 1
- 108010051210 beta-Fructofuranosidase Proteins 0.000 description 1
- 125000002619 bicyclic group Chemical group 0.000 description 1
- 239000011942 biocatalyst Substances 0.000 description 1
- 230000004071 biological effect Effects 0.000 description 1
- 230000008827 biological function Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 239000000872 buffer Substances 0.000 description 1
- 239000001110 calcium chloride Substances 0.000 description 1
- 229910001628 calcium chloride Inorganic materials 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 229910052799 carbon Inorganic materials 0.000 description 1
- 210000002421 cell wall Anatomy 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 239000003245 coal Substances 0.000 description 1
- 230000001332 colony forming effect Effects 0.000 description 1
- 239000002299 complementary DNA Substances 0.000 description 1
- 239000012141 concentrate Substances 0.000 description 1
- 238000010276 construction Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- NKLPQNGYXWVELD-UHFFFAOYSA-M coomassie brilliant blue Chemical compound [Na+].C1=CC(OCC)=CC=C1NC1=CC=C(C(=C2C=CC(C=C2)=[N+](CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=2C=CC(=CC=2)N(CC)CC=2C=C(C=CC=2)S([O-])(=O)=O)C=C1 NKLPQNGYXWVELD-UHFFFAOYSA-M 0.000 description 1
- 239000013078 crystal Substances 0.000 description 1
- 238000012217 deletion Methods 0.000 description 1
- 230000037430 deletion Effects 0.000 description 1
- 230000001627 detrimental effect Effects 0.000 description 1
- 238000010790 dilution Methods 0.000 description 1
- 239000012895 dilution Substances 0.000 description 1
- 235000020188 drinking water Nutrition 0.000 description 1
- 239000003651 drinking water Substances 0.000 description 1
- 238000004520 electroporation Methods 0.000 description 1
- 239000003623 enhancer Substances 0.000 description 1
- 239000003344 environmental pollutant Substances 0.000 description 1
- 238000003912 environmental pollution Methods 0.000 description 1
- 238000001952 enzyme assay Methods 0.000 description 1
- 238000001976 enzyme digestion Methods 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- KSEBMYQBYZTDHS-HWKANZROSA-N ferulic acid Chemical compound COC1=CC(\C=C\C(O)=O)=CC=C1O KSEBMYQBYZTDHS-HWKANZROSA-N 0.000 description 1
- 229940114124 ferulic acid Drugs 0.000 description 1
- KSEBMYQBYZTDHS-UHFFFAOYSA-N ferulic acid Natural products COC1=CC(C=CC(O)=O)=CC=C1O KSEBMYQBYZTDHS-UHFFFAOYSA-N 0.000 description 1
- 235000001785 ferulic acid Nutrition 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 238000001914 filtration Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000004927 fusion Effects 0.000 description 1
- 108020001507 fusion proteins Proteins 0.000 description 1
- 102000037865 fusion proteins Human genes 0.000 description 1
- 238000001502 gel electrophoresis Methods 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 108010037850 glycylvaline Proteins 0.000 description 1
- 108010092114 histidylphenylalanine Proteins 0.000 description 1
- 230000002779 inactivation Effects 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 239000001573 invertase Substances 0.000 description 1
- 235000011073 invertase Nutrition 0.000 description 1
- 108010000761 leucylarginine Proteins 0.000 description 1
- 108010057821 leucylproline Proteins 0.000 description 1
- 230000001533 ligninolytic effect Effects 0.000 description 1
- 108010038320 lysylphenylalanine Proteins 0.000 description 1
- 108010017391 lysylvaline Proteins 0.000 description 1
- 239000003550 marker Substances 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 229960000907 methylthioninium chloride Drugs 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 238000001426 native polyacrylamide gel electrophoresis Methods 0.000 description 1
- 238000007857 nested PCR Methods 0.000 description 1
- 229910052759 nickel Inorganic materials 0.000 description 1
- 235000015097 nutrients Nutrition 0.000 description 1
- 230000001590 oxidative effect Effects 0.000 description 1
- 235000019319 peptone Nutrition 0.000 description 1
- 238000007747 plating Methods 0.000 description 1
- 238000002264 polyacrylamide gel electrophoresis Methods 0.000 description 1
- 230000008488 polyadenylation Effects 0.000 description 1
- 235000013824 polyphenols Nutrition 0.000 description 1
- 238000011533 pre-incubation Methods 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 238000001556 precipitation Methods 0.000 description 1
- 239000000047 product Substances 0.000 description 1
- 108010014614 prolyl-glycyl-proline Proteins 0.000 description 1
- 235000019833 protease Nutrition 0.000 description 1
- 235000019419 proteases Nutrition 0.000 description 1
- 238000000746 purification Methods 0.000 description 1
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 1
- 239000011535 reaction buffer Substances 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- KUIXZSYWBHSYCN-UHFFFAOYSA-L remazol brilliant blue r Chemical compound [Na+].[Na+].C1=C(S([O-])(=O)=O)C(N)=C2C(=O)C3=CC=CC=C3C(=O)C2=C1NC1=CC=CC(S(=O)(=O)CCOS([O-])(=O)=O)=C1 KUIXZSYWBHSYCN-UHFFFAOYSA-L 0.000 description 1
- 230000004044 response Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229940102127 rubidium chloride Drugs 0.000 description 1
- 210000002966 serum Anatomy 0.000 description 1
- 108010026333 seryl-proline Proteins 0.000 description 1
- 108010071207 serylmethionine Proteins 0.000 description 1
- HELHAJAZNSDZJO-OLXYHTOASA-L sodium L-tartrate Chemical compound [Na+].[Na+].[O-]C(=O)[C@H](O)[C@@H](O)C([O-])=O HELHAJAZNSDZJO-OLXYHTOASA-L 0.000 description 1
- 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
- 239000001433 sodium tartrate Substances 0.000 description 1
- 229960002167 sodium tartrate Drugs 0.000 description 1
- 235000011004 sodium tartrates Nutrition 0.000 description 1
- 230000007928 solubilization Effects 0.000 description 1
- 238000005063 solubilization Methods 0.000 description 1
- 230000024001 sorocarp development Effects 0.000 description 1
- 238000002798 spectrophotometry method Methods 0.000 description 1
- 238000001694 spray drying Methods 0.000 description 1
- 238000003756 stirring Methods 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 238000006467 substitution reaction Methods 0.000 description 1
- 238000005486 sulfidation Methods 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- QURCVMIEKCOAJU-UHFFFAOYSA-N trans-isoferulic acid Natural products COC1=CC=C(C=CC(O)=O)C=C1O QURCVMIEKCOAJU-UHFFFAOYSA-N 0.000 description 1
- 230000002103 transcriptional effect Effects 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 150000003641 trioses Chemical class 0.000 description 1
- 108010029384 tryptophyl-histidine Proteins 0.000 description 1
- 108010017949 tyrosyl-glycyl-glycine Proteins 0.000 description 1
- 238000011144 upstream manufacturing Methods 0.000 description 1
- 238000010200 validation analysis Methods 0.000 description 1
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1
- 108010027345 wheylin-1 peptide Proteins 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/0004—Oxidoreductases (1.)
- C12N9/0055—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10)
- C12N9/0057—Oxidoreductases (1.) acting on diphenols and related substances as donors (1.10) with oxygen as acceptor (1.10.3)
- C12N9/0061—Laccase (1.10.3.2)
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
- A23L29/06—Enzymes
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/14—Fungi; Culture media therefor
- C12N1/16—Yeasts; Culture media therefor
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
- C12N15/09—Recombinant DNA-technology
- C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
- C12N15/79—Vectors or expression systems specially adapted for eukaryotic hosts
- C12N15/80—Vectors or expression systems specially adapted for eukaryotic hosts for fungi
- C12N15/81—Vectors or expression systems specially adapted for eukaryotic hosts for fungi for yeasts
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Y—ENZYMES
- C12Y110/00—Oxidoreductases acting on diphenols and related substances as donors (1.10)
- C12Y110/03—Oxidoreductases acting on diphenols and related substances as donors (1.10) with an oxygen as acceptor (1.10.3)
- C12Y110/03002—Laccase (1.10.3.2)
-
- D—TEXTILES; PAPER
- D06—TREATMENT OF TEXTILES OR THE LIKE; LAUNDERING; FLEXIBLE MATERIALS NOT OTHERWISE PROVIDED FOR
- D06L—DRY-CLEANING, WASHING OR BLEACHING FIBRES, FILAMENTS, THREADS, YARNS, FABRICS, FEATHERS OR MADE-UP FIBROUS GOODS; BLEACHING LEATHER OR FURS
- D06L4/00—Bleaching fibres, filaments, threads, yarns, fabrics, feathers or made-up fibrous goods; Bleaching leather or furs
- D06L4/40—Bleaching fibres, filaments, threads, yarns, fabrics, feathers or made-up fibrous goods; Bleaching leather or furs using enzymes
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- General Engineering & Computer Science (AREA)
- General Health & Medical Sciences (AREA)
- Biomedical Technology (AREA)
- Biochemistry (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Molecular Biology (AREA)
- Medicinal Chemistry (AREA)
- Nutrition Science (AREA)
- Virology (AREA)
- Tropical Medicine & Parasitology (AREA)
- Food Science & Technology (AREA)
- Polymers & Plastics (AREA)
- Botany (AREA)
- Physics & Mathematics (AREA)
- Biophysics (AREA)
- Plant Pathology (AREA)
- Textile Engineering (AREA)
- Enzymes And Modification Thereof (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Abstract
Description
본 발명은 신규한 라카제 단백질 및 이의 용도에 관한 것으로, 보다 자세하게는 탄닌산을 분해하는 크리포넥트리아 파라시티카(Cryphonectria parasitica) 유래의 라카제 3, 이의 코딩 영역을 포함하는 재조합 발현 벡터, 이 재조합 발현 벡터로 형질전환 된 효모 숙주세포, 이 숙주세포를 배양하여 라카제 3을 제조하는 방법 및 라카제 3의 용도에 관한 것이다.
The present invention relates to a novel laccase protein and a use thereof, and more particularly, a recombinant expression vector comprising a
라카제는 multi-copper-binding phenoloxidases(EC 1.10.3.2)로, Japanese lac tree Toxicodendron verniciflua에서 처음 검출되었다; 라카제는 다른 여러 식물뿐만 아니라 많은 곤충과 다양한 곰팡이에서도 발견되었다. 라카제는 특히 리그닌 분해(ligninolytic) 담자균(basidiomycetes)에 광범위하게 존재하고, 125종 이상의 담자균 라카제 유전자가 알려져 있다. 곰팡이에서 라카제의 생물학적 기능은 다양하여, 라카제는 리그닌 분해(delignification), 포자 형성, 색소 생산, 자실체(fruiting body) 형성, 발병을 포함한 다양한 세포의 프로세스(process)에 관여한다.Lacase is multi-copper-binding phenoloxidases (EC 1.10.3.2), first detected in the Japanese lac tree Toxicodendron verniciflua ; Lacaze was found not only in many other plants, but also in many insects and various fungi. Lacase is particularly widely present in ligninolytic basidiomycetes, and more than 125 basophilic laccase genes are known. In fungi, the biological functions of laccases vary, so that laccases are involved in the processes of various cells, including lignin degradation, spore formation, pigment production, fruiting body formation, and onset.
라카제는 최종 전자 수용체로서 산소를 이용하여 디페놀, 메톡시-친환된 모노페놀 및 방향족 아민과 같은 다수의 방향족 화합물의 산화를 촉매한다. 많은 라카제에는 특징적으로 하나의 타입-1, 하나의 타입-2 및 두 개의 타입-3 구리 이온이 존재한다. 한 번에 하나의 전자가 타입-1 구리 이온에 의해 기질로부터 제거되어 타입-2/타입-3 구리 자리로 이동되고 산소 분자가 물로 환원된다. 라카제의 낮은 기질 특이성으로 인하여, 라카제의 산업적 이용은 리그닌 분해, 폐수의 탈색, 섬유 염료 탈색, 음료수 및 식품의 처리, 효소를 기초로 한 바이오 센서를 통한 석탄의 황화와 가용화, 해로운 환경 오염물질의 변형 및 불활성화 등이 있다. 또한, 최근 연구에 의해, 이 효소의 기질 특이성이 산화환원 매개자의 존재에 의해 보다 확장될 수 있음이 밝혀졌다. 기질 특이성의 다양화 및 광범위화가 가능하다면, 라카제는 곰팡이 생물공학에서 가장 중요한 생촉매가 될 수 있을 것이다.Lacases use oxygen as the final electron acceptor to catalyze the oxidation of many aromatic compounds such as diphenols, methoxy-substituted monophenols and aromatic amines. Many laccases are characterized by one type-1, one type-2 and two type-3 copper ions. One electron at a time is removed from the substrate by
적어도 3종의 라카제가 밤나무 줄기마름병(chestnut blight) 곰팡이 크리포넥트리아 파라시티카(Cryphonectria parasitica)에 존재한다. 이 중에서도 라카제 3이 흥미롭다. 왜냐하면, 이 단백질은 구조적으로 리그닌과 관련된 페룰산 및 2,5-자일리딘과 같은 다른 통상의 공지된 곰팡이 라카제의 유도제가 아닌 탄닌산에 의해 특이적으로 유도되기 때문이다.At least three laccases are present in the chestnut blight fungus Cryphonectria parasitica . Of these, Lacaze 3 is interesting. This is because the protein is specifically induced by tannic acid, which is structurally not related to inducers of ferulic acid and other commonly known fungal laccases such as 2,5-xyldine.
식물에서 페놀 대사는 복잡하고, 꽃의 색소부터 식물 세포 벽 리그닌의 복잡한 페놀까지 다양한 화합물을 생산한다. 그러나, 탄닌산이라 알려진 페놀은, 화합물의 반응성 및 생물학적 활성 측면에서, 다른 식물의 페놀과 명백하게 구별된다. 탄닌산은 500 내지 3,000의 분자량을 가지는 수용성 페놀 화합물로 알칼로이드, 젤라틴 및 다른 단백질을 침전시키는 특징적인 특성을 보인다. 탄닌산을 다른 페놀과 구분 짓는 특성은 단백질을 침전하는 능력이다. 따라서, 탄닌산을 분해할 수 있고 탄닌산의 존재에 민감하지 않는 효소는 식물 조직 물질의 다양한 적용에 유용할 수 있다.Phenolic metabolism in plants is complex and produces compounds ranging from pigments in flowers to complex phenols in plant cell wall lignin. However, phenol, known as tannic acid, is clearly distinguished from phenols of other plants in terms of the reactivity and biological activity of the compounds. Tannic acid is a water-soluble phenolic compound having a molecular weight of 500 to 3,000 and has the characteristic characteristic of precipitating alkaloids, gelatin and other proteins. What distinguishes tannic acid from other phenols is their ability to precipitate proteins. Thus, enzymes that can degrade tannic acid and are not sensitive to the presence of tannic acid can be useful for various applications of plant tissue materials.
라카제를 비곰팡이 시스템에서 발현하는 것은 상당히 어려우므로 사카로미세스 세레비시애, 트리코더마 레세이, 아스퍼질러스 오리제, 피키아 파스토리스, 클루이베로미세스 락티스, A. 소재 및 A. 나이거를 포함한 여러 곰팡이가 라카제의 이종 발현에 이용되었다. P. 파스토리스가 라카제가 이종 발현용 숙주로서 이용되어 왔으나, 사카로미세스 세레비시애도 이용 가능함이 알려졌다. 그러나, 라카제를 활성 형태로 대량 생산할 수 있는 기술은 아직 알려져 있지 않다.
It is quite difficult to express laccase in a non-fungal system, which includes Saccharomyces cerevisiae, Trichoderma ressei, Aspergillus aurise, Pichia pastoris, Kluyberomyces lactis, A. and A. Niger. Several fungi have been used for heterologous expression of laccases. Although P. pastoris laccase has been used as a host for heterologous expression, Saccharomyces cerevisiae is known to be available. However, techniques for mass production of laccases in active form are not yet known.
본 발명자는 탄닌산을 분해할 수 있는 효소를 활성 형태로 대량 생산할 수 있는 방법을 연구하던 중 크리포넥트리아 파라시티카 유래의 라카제 3이 탄닌산을 분해하는 기능을 가지고 있음을 처음으로 규명하고, 이 유전자로 형질전환된 사카로마이세스 세레비시애를 우라실이 결핍된 배지에서 배양함으로써 효소 활성을 보유한 라카제 3을 대량 생산할 수 있음을 확인하고, 본 발명을 완성하기에 이르렀다.
The inventors of the present invention first identified that
본 발명의 한 관점은 탄닌산을 분해하는 크리포넥트리아 파라시티카(Cryphonectria parasitica) 유래의 라카제 3에 관한 것이다.One aspect of the invention relates to
본 발명의 다른 관점은 상기 라카제 3의 코딩 영역을 포함하는 재조합 발현 벡터에 관한 것이다.Another aspect of the invention relates to a recombinant expression vector comprising the coding region of
본 발명의 또 다른 관점은 상기 재조합 발현 벡터로 형질전환된 효모 숙주세포에 관한 것이다.Another aspect of the invention relates to a yeast host cell transformed with the recombinant expression vector.
본 발명의 또 다른 관점은 상기 효모 숙주세포를 배양하여 라카제 3을 제조하는 방법에 관한 것이다.Another aspect of the invention relates to a method for producing Lacase 3 by culturing the yeast host cell.
본 발명의 또 다른 관점은 상기 라카제 3, 상기 효모 숙주세포 또는 이의 배양물을 포함하는 목재 탈색 및 분해용 조성물에 관한 것이다.Another aspect of the invention relates to a composition for wood decoloration and degradation comprising the
본 발명의 또 다른 관점은 상기 라카제 3, 상기 효모 숙주세포 또는 이의 배양물을 포함하는 염색약 탈색용 조성물에 관한 것이다.Another aspect of the present invention relates to a dye discoloration composition comprising the
본 발명의 또 다른 관점은 상기 라카제 3, 상기 효모 숙주세포 또는 이의 배양물을 포함하는 식품의 탄닌산 분해용 조성물에 관한 것이다.
Another aspect of the present invention relates to a composition for decomposing tannin acid of a food comprising the
이하, 본 발명을 구체적으로 설명하도록 한다.
Hereinafter, the present invention will be described in detail.
본 발명의 '라카제 3'은 크리포넥트리아 파라시티카(Cryphonectria parasitica) 유래의 탄닌산에 의해 발현이 유도되는 단백질로서, 또한, 탄닌산(tannic acid)을 분해하는 것을 특징으로 한다.
본 발명에 따른 라카제 3의 범위는 서열번호: 7(MALRAFLSLLPALSLVTAAPSVEPYQLSKRCVNSADDRSCWGDYDLSTNYYDEAPFTNVTREYWFNIVNTTASPDGVEKIVLAVNGSIPGPTIVADWGDTVVVHVTNSMQNNGSSIHFHGIRQNFTNQNDGVASITQCPTAPGDTTTYTWRALQYGTSWWHSHFYVQAWDGVYGGIQINGPATANYDEDLGVVSMMDWDHDTADNLVLQSAVTGPPTMANGLINGMNVYTLEDNSTVGSRYEMEFTSGQRYRLRLVNTAADTHFKFTIDNHTMEVIASDFVPIQPYTTDVVNIGIGQRYDVIVTADAPSDNYWMRAIAQLACSDNDNPDNIKAIIRYSDAANSTADPTSTATADASVDECVDEPAASLVPYLAIPAGGSADVTDNFAVAVEQLAGRVDWAMGNTTFINEWGYPSIQQVYDGNNTWGESQNVIQLPQANEWVYWIVQTTMGVTHPMHMHGHDFWVLGAGTGTFDSATASLSTVNVPRRDVTMLPASGWTVIAFITDNPGVWLTHCHIAWHTSEGLAVQMVERESEIVDLIDADLMNSTCGAWNDYANKVALVQDDSGI)에 나타낸 아미노산 서열로 구성되는 단백질 및 상기 단백질의 기능적 동등물을 의미한다. '기능적 동등물'이란, 아미노산의 부가, 치환 또는 결실의 결과 상기 서열번호: 7에 나타낸 아미노산 서열과 적어도 70% 이상, 바람직하게는 80% 이상, 보다 바람직하게는 90% 이상의 서열 상동성을 갖는 것으로, 서열번호: 7로 표시되는 단백질과 실질적으로 동질의 생리활성을 나타내는 단백질을 말한다. '실질적으로 동질의 생리활성'이란 탄닌산을 분해하는 활성을 가지고 있음을 의미한다.Lacquer scope of
본 발명의 라카제 3의 발현을 위해, 먼저 라카제 3의 코딩 영역을 적절한 발현 벡터에 작동 가능하게 연결시켜 재조합 발현 벡터를 제조하는 것이 바람직하다. 여기서, 라카제 3의 코딩 영역은 성숙형(matured, 분비 서열이 제거된) 라카제 3의 코딩 영역인 것이 바람직하다.For the expression of
본 발명의 재조합 발현 벡터는 라카제 3의 코딩 영역 외에, 형질전환체의 선별을 위한 선택성 마커와 숙주세포에서의 증식을 위한 복제 기점을 포함할 수 있다. 또한, 본 발명의 재조합 발현 벡터는 숙주세포에서 작용할 수 있는 전사 또는 해독 조절 서열을 원하는 바에 따라 본 발명의 라카제 3의 코딩 영역에 작동 가능하게 연결시켜 포함할 수 있다.In addition to the coding region of
본 발명에서 '조절 서열'은 본 발명의 라카제 3 발현에 필수적이거나 이로운 핵산 서열들을 말한다. 각각의 조절 서열은 폴리펩타이드(즉, 라카제 3)를 코딩하는 핵산 서열에 천연적 또는 외래적일 수 있다. 이러한 조절 서열에는 이에 제한되는 것은 아니지만, 분비 서열, 폴리아데닐화 서열, 프로펩타이드(propeptide) 서열, 프로모터, 인핸서(enhancer) 또는 업스트림(upstream) 활성화 서열 및 전사 종결인자 등을 포함한다. 본 발명에서 조절 서열은 바람직하게는 프로모터와 분비 서열을 포함한다. 다른 조절 서열들은 본 발명의 라카제 3의 발현양을 더욱 증가시키기 위해 선택적으로 포함될 수 있다.In the present invention, 'regulatory sequence' refers to nucleic acid sequences essential or beneficial for expression of
본 발명에서 '프로모터' 본 발명의 라카제 3 전사를 개시하는데 필수적인 핵산 서열을 말한다. 본 발명의 프로모터는 구성성(constitutive) 또는 유도성(inducible)일 수 있다. 구성성 프로모터는 유도성 프로모터 보다 적은 양의 라카제 3을 발현하지만, 형질전환체 자체를 이용하는 경우에는 보다 바람직한 형태이다. 유도성 프로모터는 구성성 프로모터 보다 많은 양의 라카제 3을 발현할 수 있으며, 분리 정제된 라카제 3을 활용하는 경우에는 구성성 프로모터 보다 바람직한 형태다.In the present invention, 'promoter' refers to a nucleic acid sequence essential for initiating the
본 발명의 숙주세포에서 작용하는 프로모터의 예에는 효모 알파-메이팅 시스템(α-mating system)의 프로모터, 효모 트리오스 포스파타아제 이소머라제(triose phosphatase isomerase; TPI)의 프로모터, 효모의 해당과정에 관여하는 유전자들(glycolytic genes) 또는 알코올 탈수효소 (alcohol dehydrogenase; ADH) 유전자의 프로모터 및 효모의 갈락토오스 대사에 관여하는 효소들(예를 들면, GAL1(galactose kinase) 및 GAL10(uridine diphosphoglucose 4-epimerase))의 프로모터, GPD(glyceraldehyde-3-phosphate dehydrogenase), MOX(methano oxidase), AOX(alcohol oxidase) 프로모터 등이 포함된다.Examples of promoters that act in the host cell of the present invention include a promoter of the yeast alpha-mating system, a promoter of the yeast triose phosphatase isomerase (TPI), and a glycolytic process of yeast. Promoters of glycolytic or alcohol dehydrogenase (ADH) genes and enzymes involved in yeast galactose metabolism (e.g., galactose kinase (GAL1) and uridine diphosphoglucose 4-epimerase (GAL10) ), GPD (glyceraldehyde-3-phosphate dehydrogenase), MOX (methano oxidase), AOX (alcohol oxidase) promoter and the like.
본 발명에서 '분비 서열(시그널 펩타이드)'은 발현된 단백질이 세포막 밖으로 수송되도록 유도하는 아미노산 서열을 말한다. 일반적으로 세포막 밖으로 수송되는 표면 단백질 또는 분비 단백질은 세포막에서 모티브 펩티다제(signal peptidase)에 의해 잘려지게 되는 N-말단 서열을 가지고 있다. 본 발명에서는 분비 서열로 이에 제한되는 것은 아니지만, 알파-인자(α-factor) 분비 서열, 킬러 톡신 리더(killer toxin leader) 분비 서열, 인버타제(invertase) 분비 서열, 알파-아밀라제(α-amylase) 분비 서열 등이 이용될 수 있다. 본 발명에서는 벼 유래의 아밀라제 1A(Ramy1A)의 시그널 펩타이드(ASP)가 특히 바람직하다.In the present invention, the 'secretory sequence (signal peptide)' refers to an amino acid sequence that induces the expressed protein to be transported out of the cell membrane. In general, surface proteins or secreted proteins that are transported out of the cell membrane have an N-terminal sequence that is cut by the motive peptidase in the cell membrane. In the present invention, but not limited to the secretion sequence, alpha-factor (α-factor) secretion sequence, killer toxin leader secretion sequence, invertase secretion sequence, alpha-amylase (α-amylase) Secretion sequences and the like can be used. In the present invention, rice peptide amylase 1A ( Ramy 1A) signal peptide (ASP) is particularly preferred.
본 발명에서는, 라카제 3 유전자의 도입 및 발현을 위해서 공지된 효모용 발현 벡터를 사용할 수 있다. 본 발명의 실시예에서는 pYEGPD-TER 및 pYEGAL-TER을 이용하였다. 상기 벡터는 GPD 프로모터와 갈락토스-1-포스페이트 우리디릴 트랜스퍼라제 (GAL7) 터미네이터를, 그리고 GAL1 프로모터와 GAL7 터미네이터를 각각 보유하고 있다.In the present invention, a known yeast expression vector can be used for the introduction and expression of the
본 발명의 재조합 발현 벡터는 도 1a에 나타낸 개열 지도를 가지는 pYEGLAC3 또는 도 1b에 나타낸 개열 지도를 가지는 'pYEGALLAC3'이 바람직하다. 유도성 프로모터인 GAL1 프로모터를 포함하는 'pYEGALLAC3'이 더욱 바람직하다.As for the recombinant expression vector of this invention, pYEGLAC3 which has a cleavage map shown in FIG. 1A, or "pYEGALLAC3" which has a cleavage map shown in FIG. 1B is preferable. More preferred is 'pYEGALLAC3' comprising the GAL1 promoter, which is an inducible promoter.
본 발명에 이용할 수 있는 효모는 사카로미세스속, 트리코더마속, 아스퍼질러스속, 피키아속, 클루이베로미세스속 등이 있으나, 이에 제한되는 것은 아니다. 바람직하게는 사카로미세스속 유래의 효모이고, 보다 바람직하게는 사카로미세스 세레비시애, 사카로미세스 파스토리아누스, 사카로미세스 바야누스, 사카로미세스 크루베리 등이다. 본 발명의 실시예에서는 S. 세레비시애 2805(MATα pep4::HIS3 prb1-δ can1 GAL2 his3 -200 ura3 -52)를 이용하였다.Yeasts that can be used in the present invention include, but are not limited to, Saccharomyces genus, Trichoderma genus, Aspergillus genus, Pichia genus, Cluiveromyces genus and the like. Preferably it is yeast derived from the genus Saccharomyces, More preferably, it is Saccharomyces cerevisiae, Saccharomyces pastorinus, Saccharomyces bayanus, Saccharomyces berry. In an embodiment of the present invention, S. cerevisiae 2805 ( MATα pep4 :: HIS3 prb1-δ can1 GAL2 his3 -200 ura3 -52 ).
본 발명의 재조합 발현 벡터를 숙주세포에 도입하는 방법으로는, 이제 제한되는 것은 아니지만, 인산칼슘 또는 염화칼슘/염화루비듐법, 리튬 아세테이트법, 일렉트로포레이션법, 일렉트로인젝션법, PEG 등의 화학적인 처리에 의한 방법, 유전자 총 등을 사용하는 방법 등을 들 수 있다. 구체적으로 효모는 (1) Simon, M.I. et al., editors, Guide to Yeast Genetics and Molecular Biology, Methods in Enzymology, vol.194, p.182-7, Academic press, Inc. New York; (2) Ito, et al. Journal of Bacteriology, 1983, vol.153, p.163; (3) Hinnen et al. Proceedings of the National Academy of Sciences USA, 1978, vol.75, p.1920 및 (4) Clontech Laboratories, Inc, Palo Alto. Calif., USA(YeastmakerTM Yeast Transformation System Kit)에 공지된 기술을 이용하여 형질전환시킬 수 있다.As a method of introducing the recombinant expression vector of the present invention into a host cell, chemical treatment such as, but not limited to, calcium phosphate or calcium chloride / rubidium chloride method, lithium acetate method, electroporation method, electroinjection method, PEG, etc. The method by using, the method using a gene gun, etc. are mentioned. Specifically, yeast is described by (1) Simon, MI et al., Editors, Guide to Yeast Genetics and Molecular Biology, Methods in Enzymology, vol.194, p.182-7, Academic press, Inc. New York; (2) Ito, et al. Journal of Bacteriology, 1983, vol. 153, p. 163; (3) Hinnen et al. Proceedings of the National Academy of Sciences USA, 1978, vol. 75, p.1920 and (4) Clontech Laboratories, Inc, Palo Alto. Transformation can be made using techniques known from Calif., USA (Yeastmaker ™ Yeast Transformation System Kit).
본 발명에서는 C. 파라시티카 유래의 라카제 3의 코딩 영역을 포함하는 재조합 발현 벡터로 형질전환된 효모 숙주세포를 우라실(uracil)이 결핍된 배지에서 배양하여 라카제 3을 제조한다.In the present invention, the
본 발명에서, "우라실(ura-) 결핍 배지"란, 우라실이 포함되지 않으면서, 숙주세포가 생존 가능하고, 라카제 3이 발현될 수 있는 배지를 의미한다. 본 발명의 우라실 결핍 배지는, 바람직하게는 아미노산이 포함되지 않은 효모 질소 베이스(yeast nitrogen base without amino acids), 아데닌, 트립토판, 카사미노산(casamino acid), 덱스트로스를 포함하며, 보다 바람직하게는 5~8 g/l 아미노산이 포함되지 않은 효모 질소 베이스, 0.01~0.05 g/l 아데닌, 0.01~0.05 g/l 트립토판, 3~9 g/l 카사미노산 및 15~25 g/l 덱스트로스를 포함한다.In the present invention, "ura - deficient medium" means a medium in which host cells are viable and
한 양태로서, 본 발명의 우라실 결핍 배지는 6.7 g/l 아미노산이 포함되지 않은 효모 질소 베이스, 0.03 g/l 아데닌, 0.03 g/l 트립토판, 5 g/l 카사미노산, 20 g/l 덱스트로스, 20 g/l 아가를 포함할 수 있다.In one embodiment, the uracil deficient medium of the present invention comprises a yeast nitrogen base that does not include 6.7 g / l amino acid, 0.03 g / l adenine, 0.03 g / l tryptophan, 5 g / l casamino acid, 20 g / l dextrose, 20 g / l agar.
본 발명의 한 양태로서, 형질전환된 숙주세포를 우라실이 포함된 배지에서 배양하는 경우, 이 배지에 아스파르틸 프로테아제 억제제(aspartyl protease inhibitor)를 추가하는 것이 바람직하다. 상기 억제제가 라카제 3의 활성 상실을 억제할 수 있기 때문이다. 상기 억제제의 대표적인 예로는 펩스타틴(pepstatin)을 들 수 있다.In one embodiment of the present invention, when the transformed host cell is cultured in a medium containing uracil, it is preferable to add an aspartyl protease inhibitor to the medium. This is because the inhibitor can inhibit the loss of activity of
한편, 라카제 3은 숙주세포의 성장에 해로운 영향을 미칠 수 있다. 본 발명에서는 배양이 경과함에 따라 라카제 3의 활성이 감소하는 것을 확인하였다. 따라서, 본 발명에서는 라카제 3이 발현되는 상태인 경우, 단기간 배양하는 것이 적절하며, 구체적으로 배양 기간은 1 내지 5일, 바람직하게는 2 내지 4일로 한다. 여기서, 라카제 3이 발현되는 상태란, 라카제 3이 유도성 프로모터의 조절 하에 있는 경우에는 상응하는 유도제가 배지에 포함되어 라카제 3의 발현이 유도되는 상태이고, 라카제 3이 구성성 프로모터의 조절하에 있는 경우에는 숙주세포가 생존한 상태라면 라카제 3의 발현이 일어나므로 숙주세포가 생존한 상태, 즉 배양 중인 상태를 의미한다.On the other hand,
본 발명에 따라 생산된 라카제 3은 효소 활성을 유지하는 것을 특징으로 한다. 예를 들면, 라카제 3은 탄닌산과 같은 페놀 화합물을 분해할 수 있다.
본 발명의 라카제 3은 배양물로부터 당업계에 공지된 방법에 의해 분리될 수 있다. 예를 들어, 폴리펩타이드는 이로써 제한되는 것은 아니지만, 원심분리, 여과, 추출, 분무 건조, 증발 또는 침전을 포함한 전통적인 방법에 의해 배지로부터 분리될 수 있다. 더 나아가, 폴리펩타이드는 크로마토그래피, 전기영동, 분별용해도, SDS-PAGE 혹은 추출을 포함하여 일반에 공지된 다양한 방법을 통해서 정제될 수 있다.Lacase 3 of the present invention can be isolated from culture by methods known in the art. For example, the polypeptide can be separated from the medium by conventional methods including, but not limited to, centrifugation, filtration, extraction, spray drying, evaporation or precipitation. Furthermore, polypeptides can be purified through a variety of methods known in the art, including chromatography, electrophoresis, fractional solubility, SDS-PAGE or extraction.
탄닌산을 분해하는 것을 특징으로 하는 본 발명의 라카제 3은 펄프 산업, 섬유 산업, 식품 산업 등에 적용될 수 있다. 여기서, 라카제 3의 코딩 영역을 포함하는 재조합 발현 벡터로 형질전환된 효모 숙주세포 자체, 이의 배양물 또는 이 배양물로부터 분리 정제된 라카제 3이 이용될 수 있다.
본 발명의 라카제 3은 펄프 산업에서 목재의 탈색 및 분해에 이용될 수 있다. 또한, 라카제 3은 섬유 산업에서 염색약의 탈색에 이용될 수 있다. 예를 들면, 염색약의 폐수는 환경 오염원으로 작용하므로 이의 탈색이 필수적이다. 실시예 3에 나타낸 바와 같이 본 발명의 라카제 3은 말라카이트 그린 G를 분해할 수 있다. 또한, 본 발명의 라카제 3은 식품에서 식품의 탄닌산 분해하는데 이용될 수 있다. 탄닌산은 떫은 맛을 내므로 필요에 따라 제거하는 것이 바람직할 수 있다.
Lacase 3 of the present invention can be used in the pulp industry to decolorize and decompose wood. In addition,
본 발명에 의하면, 탄닌산을 분해할 수 있는 라카제를 효소 활성이 유지된 상태로 대량 생산할 수 있다.According to the present invention, it is possible to mass-produce a laccase capable of decomposing tannic acid in a state in which enzyme activity is maintained.
본 발명의 라카제 3은 펄프, 식품, 섬유 산업 등 다양한 분야에서 이용할 수 있다.
Lacase 3 of the present invention can be used in various fields such as the pulp, food, and textile industries.
도 1a는 본 발명의 재조합 발현 벡터 pYEGLAC3의 개열 지도를 나타낸 것이다.
도 1b는 본 발명의 재조합 발현 벡터 pYEGALLAC3의 개열 지도를 나타낸 것이다.
도 2a는 본 발명의 형질전환체 TYEGLAC3-1을 ura- 선택 배지에서 5일간 배양하며 배양 일수별 라카제 3의 발현 정도를 나타낸 것이다.
도 2b는 본 발명의 형질전환체 TYEGLAC3-1의 ura- 선택 배지에서 5일간 배양하며, 배양 일수별 라카제 3의 활성도와 세포 성장을 나타낸 것이다.
도 2c는 본 발명의 형질전환체 TYEGALLAC3-6을 YEPD 배지(non-induction, NI) 또는 갈락토오스가 보충된 ura- 선택 배지(induction, I)에서 5일간 배양하며, 배양 일수별 라카제 3의 활성도와 세포 성장을 나타낸 것이다.
도 3은 본 발명에 따른 형질전환체 TYEGLAC3-1의 배양물 상층액을 전기영동한 후 DMOP 기질 용액으로 염색한 결과(A), 쿠사미 블루로 염색한 결과(B), 웨스턴 블롯으로 분석한 결과(C)를 각각 나타낸 것이다(레인 1 및 2: Trametes versicolor의 라카제 1 및 5mU, 레인 3: 모방 형질전환체의 배양물 상층액, 레인 4: TYEGLAC3-1의 배양물 상층액 레인 5: TYEGLAC3-1의 배양물 상층액의 40배 농축액).
도 4는 본 발명에 따른 형질전환체 TYEGLAC3-1을 탄닌산이 보충된 배지에서 배양시키고, 콜로니 주변의 발색 정도를 나타낸 것이다(1: 모방 형질전환체, 2: TYEGLAC3-1, 3: TYEGLAC3-5, 4: TYEGLAC3-7).
도 5는 다양한 프로테아제에 의한 라카제 3 활성의 보호 여부를 DMOP 기질 용액으로 염색시켜 확인한 결과를 나타낸 것이다(1: 모방 형질전환체, 2: TYEGLAC3-1, 3: TYEGLAC3-5, YEPD: 신선한 YEPD, SCB: YEPD에서 배양된 TYEGLAC3-1의 배양물 상층액)
도 6은 본 발명에 따른 라카제 3의 염색약 탈색 효과를 나타낸 것이다(1: 음성 대조군(ura- 배지), lac3 발현 형질전환체의 배양액-약 10~20mU, 3: 2번의 2 반복을 위한 동일한 배양액 동량 첨가, 4: 시판하는 라카제 (Trametes vericolor 균주로부터 분리된 라카제), 5: 4번과 동일한 라카제 3-10mU).1A shows a cleavage map of the recombinant expression vector pYEGLAC3 of the present invention.
Figure 1b shows a cleavage map of the recombinant expression vector pYEGALLAC3 of the present invention.
Figure 2a shows the expression level of
Figure 2b is cultured for 5 days in the ura - selection medium of the transformant TYEGLAC3-1 of the present invention, it shows the activity and cell growth of
FIG. 2C shows that the transformant TYEGALLAC3-6 of the present invention is incubated for 5 days in YEPD medium (non-induction, NI) or ura - selective medium (induction, I) supplemented with galactose, and activity of
Figure 3 is a result of staining with a DMOP substrate solution after electrophoresis of the culture supernatant of the transformant TYEGLAC3-1 according to the present invention (A), Kusami blue staining (B), analyzed by Western blot Results (C) are shown respectively (
Figure 4 is a transformant TYEGLAC3-1 according to the present invention is cultured in a medium supplemented with tannic acid, and shows the degree of color development around colonies (1: mimetic transformant, 2: TYEGLAC3-1, 3: TYEGLAC3-5 , 4: TYEGLAC3-7).
Figure 5 shows the results confirmed by staining with DMOP substrate solution for the protection of
Figure 6 shows the dye bleaching effect of
이하, 실시예는 오로지 본 발명을 보다 구체적으로 설명하기 위한 것으로서, 본 발명의 요지에 따라 본 발명의 범위가 이들 실시예에 의해 제한되지 않는다는 것은 본 발명이 속하는 기술분야에서 통상의 지식을 가진 자에게 있어서 자명할 것이다.
It will be apparent to those skilled in the art that various modifications and variations can be made in the present invention without departing from the spirit or scope of the invention as defined by the appended claims. It will be obvious to you.
실시예 1: 재료 및 방법Example 1: Materials and Methods
1-1. 균주 및 배양 조건1-1. Strains and Culture Conditions
플라스미드는 Escherichia coli HB010 또는 DH5α에서 보관하고 증폭시켰다. Cryphonectria parasitica 유래의 라카제 3을 코딩하는 cDNA는 종래의 것을 이용하였고(Chung HJ et al. Mol Plant-Microbe Interact 2008, 21:1582-1590), lac3의 이종 생산에 S. 세레비시애 2805(MATα pep4::HIS3 prb1-δ can1 GAL2 his3-200 ura3-52)가 이용되었다.Plasmids were stored and amplified in Escherichia coli HB010 or DH5α. CDNA encoding a third lacquer of Cryphonectria parasitica was derived using the fact that a prior (Chung HJ et al Mol Plant- Microbe Interact 2008, 21:. 1582-1590), the production of the heterologous S. lac3 celebrity bicyclic Ke 2805 (MATα pep4 :: HIS3 prb1-δ can1 GAL2 his3-200 ura3-52 ) was used.
S. 세레비시애는 YEPD 배지(효모 추출물 10g/l; 펩톤 20g/l; 덱스트로스 20g/l)에서 유지시켰다. 우라실이 결핍된(ura-) 선택 배지(6.7 g/l 아미노산이 포함되지 않은 효모 질소 베이스, 0.03 g/l 아데닌 및 트립토판, 5 g/l 카사미노산, 20 g/l 덱스트로스, 20 g/l 아가)가 30℃에서 형질전환체를 스크리닝하는데 이용되었다. 24시간 동안 배양된 우라실 선택 배양물 5ml로부터 일차 접종액을 준비하고, 1 x 107 세포를 40 ml의 YEPD 브로스(broth) 또는 ura- 선택 브로스를 포함하는 300-ml 엘렌마이어 플라스크(Erlenmeyer flask)로 이동시켰다. 발현 배양물을 연속 교반(200rpm)하며 2-3일 동안 30℃에서 배양하고 3,000g에서 원심분리한 후 배양물 상층액을 회수하여 라카제의 활성을 분석하였다.
S. cerevisiae was maintained in YEPD medium (10 g / l yeast extract; 20 g / l peptone; 20 g / l dextrose). Uracil - deficient medium (ura-) yeast nitrogen base without 6.7 g / l amino acid, 0.03 g / l adenine and tryptophan, 5 g / l casamino acid, 20 g / l dextrose, 20 g / l Agar) was used to screen for transformants at 30 ° C. Prepare a primary inoculum from 5 ml of uracil selective culture incubated for 24 hours, and 1 x 10 7 cells in a 300-ml Erlenmeyer flask containing 40 ml of YEPD broth or ura - selective broth. Moved to. The expression culture was incubated at 30 ° C. for 2-3 days with continuous stirring (200 rpm), centrifuged at 3,000 g, and the culture supernatant was recovered to analyze the activity of laccase.
1-2. 플라스미드 작제1-2. Plasmid Construction
lac3 유전자의 cDNA 클론은 종래의 것을 이용하였다(Chung HJ et al. Mol Plant-Microbe Interact 2008, 21:1582-1590). 라카제 3 단백질의 성숙 펩타이드의 5' 및 3' 말단에, 프라이머로 포워드 5'-GGTCTAGAATGCAGGTGCTGAACACC-3'(서열번호: 1)와 리버스 5'-GGTCTAGATTATATGCCC GAATC GTCC-3'(서열번호: 2) 및, 오버랩 포워드 5'-AACTTGA CAGCCGGGGCTCCCAGTGTCGAG-3'(서열번호: 3)와 오버랩 리버스 5'-CTCGAC ACTGGGA GCCCCGG CTGTCAAGTT-3'(서열번호: 4)를 이용하는 오버랩 연장 PCR을 통해, XbaI 제한 효소 자리를 생성시켜, 벼 유래의 아밀라제 1A(Ramy1A)의 시그널 펩타이드(ASP)와 융합하였다. 증폭된 유전자를 pGEM T-Easy 벡터(Promega)로 클로닝하고, 제한효소 소화를 통해 분석하고, DNA 서열분석을 통해 확인하였다. 효모 발현 벡터를 작제하기 위해, pGEM T-Easy 벡터를 XbaI으로 소화시켜 ASP/LAC3 융합 절편을 잘라낸 후 pYEGPD-TER 및 pYEGAL-TER로 삽입하였다. 상기 벡터는 글리세르알데히드-3-포스페이트 디하이드로게나제(GPD) 프로모터와 갈락토스-1-포스페이트 우리디릴 트랜스퍼라제 (GAL7) 터미네이터를, 그리고 갈락토키나제 1 (GAL1) 프로모터와 GAL7 터미네이터를 각각 보유하고 있다. 이렇게 형성된 플라스미드는 pYEGLAC3(도 1a) 및 pYEGALLAC3(도 1b)으로 명명하였다.
The cDNA clone of the lac3 gene was used conventionally (Chung HJ et al. Mol Plant-Microbe Interact 2008, 21: 1582-1590). At the 5 'and 3' ends of the mature peptides of the
1-3. 사카로마이세스 세레비시애의 형질전환 및 선택1-3. Transformation and Selection of Saccharomyces cerevisiae
작제된 재조합 벡터는 리튬 아세테이트 방법을 이용하여 S. 세레비시애 2805로 도입되었고, 이렇게 형성된 형질전환체는 ura- 배지에서 스크리닝하였다. 형질전환체로부터 샘플링된 플라스미드를 이용하여 콜로니 PCR과 E. coli로의 형질전환을 실시하여 효모에서 재조합 플라스미드의 존재를 확인하였다. pYEGLAC3가 도입된 효모는 TYEGLAC3으로, pYEGALLAC3가 도입된 효모는 TYEGALLAC3으로 명명하였다.The constructed recombinant vector was introduced into S. cerevisiae 2805 using the lithium acetate method, and the transformants thus formed were screened in ura − medium. Colony PCR and transformation with E. coli were performed using plasmids sampled from the transformants to confirm the presence of recombinant plasmids in yeast. Yeast introduced with pYEGLAC3 was named TYEGLAC3 and yeast introduced with pYEGALLAC3 was named TYEGALLAC3.
효모에 도입된 플라스미드의 안정성은 다음과 같이 측정하였다. 비선택성 YEPD 배지에서 배양된 시료를 멸균된 H2O로 200 CFU(colony-forming units)까지 연속 희석시킨 후 ura- 선택성 및 비선택성 플레이트에 플레이팅하였다. 그리고 CFU의 상대치가 확인되었다.
Stability of the plasmid introduced into the yeast was measured as follows. Samples incubated in non-selective YEPD medium were serially diluted with sterile H 2 O to 200 colony-forming units (CFU) and then plated on ura - selective and non-selective plates. And the relative value of CFU was confirmed.
1-3. 라카제의 분석1-3. Analysis of laccase
배양물의 여과물내 라카제 활성은 pH 3.4의 소듐 타르테이트 완충액에 녹인 10mM 2,6-디메토페놀(2,6-dimethophenol, DMOP)을 기질로 이용하여 분광광도 분석법으로 확인하였다. 라카제 유니트(unit)는 25℃에서 1.0/분 A468 증가로 정의하였다.Lacase activity in the filtrate of the culture was confirmed by spectrophotometric analysis using 10
천연(native) 겔의 활성 염색을 위해, 천연의 PAGE(polyacrylamide gel electrophoresis)를 비변성(non-denaturing) 조건에서 수행하였다. 라카제 활성은 DMOP 기질 용액을 이용하여 겔 내에서 가시화되었다.For active staining of native gels, native polyacrylamide gel electrophoresis (PAGE) was performed under non-denaturing conditions. Lacase activity was visualized in the gel using DMOP substrate solution.
우라실이 결핍된 선택 배지로 0.5%(w/v) 탄닌산을 추가하여 탄닌산이 보충된 배지를 준비하였다. 그리고, 형질전환체를 탄닌산이 보충된 배지에서 배양시켜 배지의 발색을 통해 라카제의 활성을 가시화하였다.
A medium supplemented with tannic acid was prepared by adding 0.5% (w / v) tannic acid to the selection medium lacking uracil. The transformants were then cultured in a medium supplemented with tannic acid to visualize the activity of laccase through the color development of the medium.
1-4. 프로테아제 억제 분석1-4. Protease Inhibition Assay
라카제의 활성 억제가 배양 배지내 프로테아제의 존재 때문인지를 확인하기 위해, 아프로티닌, EDTA, E-64 프로테아제 억제제, 루펩틴, 펩스타틴 및 PMSF(phenylmethylsulphonyl fluoride)와 같은 여러 종류의 프로테아제 억제제를 25℃에서 10시간 동안 배양 배지와 함께 전(pre)전치배양하였다. 이 전치배양된 배양 배지를 라카제 활성을 포함하는 배양 배지와 혼합하여 추가로 24시간 동안 정치배양한 후 잔류 라카제 활성을 측정하였다.
To determine whether the inhibition of laccase activity is due to the presence of proteases in the culture medium, several protease inhibitors such as aprotinin, EDTA, E-64 protease inhibitors, lupetin, pepstatin and phenylmethylsulphonyl fluoride (PMSF) may be used. Pre-incubation with the culture medium was carried out for 10 hours at ℃. This precultured culture medium was mixed with the culture medium containing the laccase activity and left to culture for an additional 24 hours, and then the residual laccase activity was measured.
1-5. 발현된 라카제 3의 웨스턴 블롯 분석1-5. Western blot analysis of expressed
잔기 231부터 567까지의 도메인을 포함하는 일부 유전자의 작제물을 헥사히스티딘(hexahistidine) 융합 단백질로서 E. coli에서 발현하였고, 제조업자의 설명문(Takara)에 따라 니켈 친화 크로마토그래피로 정제하였다. 일부 라카제 3을 코딩하는 cDNA는 프라이머 5'-GCAGCTCGAG CTCGAGGACAACAGC-3'(포워드)(서열번호: 5) 및 5'-CCCAAGCTT TTATATGCCCGA-3'(리버스)(서열번호: 6)를 이용하여 PCR로 증폭하였다. 프라이머는 각각 제한효소 XhoI와 HindIII를 통합하도록 변형되었다. 절단된 lac3(1014bp)을 발현 벡터 pColdII DNA(Takara)의 XhoI 및 HindIII 자리로 삽입하였다. 이렇게 형성된 재조합 플라스미드를 E.coli 균주 BL21로 형질전환시켰다. 재조합 라카제 3의 유도, 정제 및 항-헥사히스티딘 항체를 이용한 확인은 제조업자의 설명문에 따라 진행되었다.Constructs of some genes comprising domains from residues 231 to 567 were expressed in E. coli as hexahistidine fusion proteins and purified by nickel affinity chromatography according to the manufacturer's instructions (Takara). CDNA encoding some
항-CpLac3 항체는 100㎍의 정제된 일부 라카제 3을 6주령의 BALB/c 마우스로 주입하고, 2주 후 불완전 프로인드 어주반트(Freund's adjuvant)에 에멀전화시킨 동량의 라카제로 부스팅하여 수득하였다. 부스터 주입 후 5일째에 다중혈청을 수득하여 웨스턴 블롯 분석을 수행하였다.
Anti-CpLac3 antibodies were obtained by injecting some 100 μg of purified
실시예 2. 결과Example 2. Results
2-1. 형질전환된 S. 세레비시애의 분석2-1. Analysis of Transformed S. cerevisiae
재조합 플라스미드를 나타내는 S. 세레비시애 형질전환체 10 내지 20개를 ura- 배지에서 선별하였다. 이 형질전환체로부터 얻은 DNA 표본을 이용하여 콜로니 PCR을 실시한 결과 1.8kb의 DNA 절편이 증폭되어, 재조합 플라스미드가 효모로 전달되었음을 알 수 있었다. 또한, 모든 선택된 형질전환체로부터 얻은 DNA 표본을 이용하여 E.coli 형질전환한 결과, 효모에 재조합 플라스미드가 존재함을 재확인할 수 있었다.
10-20 S. cerevisiae transformants representing recombinant plasmids were selected in ura - medium. Colony PCR was performed on the DNA samples obtained from the transformants. The 1.8 kb DNA fragment was amplified and the recombinant plasmid was delivered to the yeast. In addition, E. coli transformation with DNA samples from all selected transformants confirmed that the recombinant plasmid was present in yeast.
2-2. 구성성 프로모터를 이용한 LAC3 단백질의 발현2-2. Expression of LAC3 Protein Using a Constitutive Promoter
GPD 프로모터에 의한 라카제 3을 코딩하는 트랜스 유전자의 발현은 효소와 기질로서 각각 배양물의 상층액과 DMOP를 이용하는 효소 분석법으로 확인되었다. YEPD 배지에서 3일 동안 배양된 형질전환체의 배양물 상층액에서 효소 활성을 측정한 결과, 라카제 활성이 검출되지 않았다. 그러나, ura- 선택 브로스로부터 준비된 배양물 상층액의 경우, 모든 형질전환체가 라카제 활성을 나타내었다. 가장 높은 효소 활성을 나타낸 형질전환체 TYEGLAC3-1이 추가 분석에 이용되었다. 형질전환체 TYEGLAC3-1을 ura- 선택 배지에서 5일 동안 배양하고, 이 시료를 분석하여 재조합 라카제 3의 시간 경과에 따른 발현 패턴을 얻었다(도 2a). 가장 높은 라카제 활성은 배양 2일 후에 측정되었는데, 20.0 mU/ml 배양물 상층액이었다. 배양이 진행됨에 따라 효소 활성이 빠르게 감소하였다(도 2b).The expression of the trans
배양물 상층액의 천연 겔 전기영동과 DMOP 기질 용액으로의 염색 결과, 라카제 활성을 보이는 밴드의 존재가 확인되었다(도 3의 A). 천연 겔의 쿠사미 블루 염색 결과, 상응하는 위치에서 단백질 밴드의 존재를 확인할 수 있었다(도 3의 B). 또한, 웨스턴 블롯 분석을 통해 상응하는 단백질 밴드의 면역 반응성을 확인할 수 있었다(도 3의 C). 비특이적 배지 및 영양이 풍부한 YEPD 배지에서 배양된 형질전환체 TYEGLAC3-1의 배양물 상층액에서는 라카제의 활성 및 면역 반응성 밴드 모두 나타나지 않았다. 이러한 결과는 ura- 선택이 형질전환체가 라카제 활성을 나타내는데 필수적이고, ura- 선택 배양 배지에서 유지된다는 것을 보여준다. 또한, 이러한 결과들은 배양물 상층액내 라카제 활성이 lac3 유전자의 단백질 산물 때문임을 보여준다(도 3).Natural gel electrophoresis of the culture supernatant and staining with DMOP substrate solution confirmed the presence of a band showing laccase activity (FIG. 3A). Kusami blue staining of the natural gel, it was confirmed the presence of a protein band at the corresponding position (Fig. 3 B). In addition, Western blot analysis confirmed the immune reactivity of the corresponding protein band (Fig. 3C). Culture supernatants of transformant TYEGLAC3-1 cultured in non-specific and nutrient rich YEPD media did not show any activity and immune responsive bands of laccase. These results show that ura - selection is essential for the transformant to exhibit laccase activity and is maintained in ura - selection culture medium. These results also show that the laccase activity in the culture supernatant is due to the protein product of the lac3 gene (FIG. 3).
C. 파라시티카 유래의 라카제 3은 탄닌산에 반응하기 때문에 탄닌산이 보충된 배지를 이용하여, 발현된 라카제 3에 의한 탄닌산의 산화를 측정하였다. 0.5% 탄닌산이 보충된 ura- 선택 배지를 포함하는 플레이트를 준비하여 형질전환된 세포를 배양하였다. 도 4에 나타낸 바와 같이, 형질전환체의 콜로니 주변에서 짙은 갈색이 나타났다. 반면, 벡터만이 형질전환된 세포(모방 형질전환체) 주변에서는 그러한 색상 반응이 나타나지 않았다. 이는 형질전환체는 라카제 3을 발현하여 배지로 분비할 수 있고, 발현된 재조합 라카제 3은 탄닌산과 같은 페놀 화합물을 산화시키는 생화학적 특성을 보유한다는 것을 의미한다.
Since
2-3. 재조합 균주의 플라스미드 안정성 및 세포 성장2-3. Plasmid Stability and Cell Growth of Recombinant Strains
선택 배지 뿐만 아니라 비선택성 YEPD 배지에서 CFU를 측정하고, 헤마토사이토메터(haematocytometer)를 이용하여 세포의 수를 카운팅함으로써 플라스미드 안정성과 세포 성장을 확인하였다. 형질전환체 TYEGLAC3-1 및 2개의 임의적으로 선택된 형질전환체 TYEGLAC3-5 및 -7에 대하여 플라스미드 안정성을 확인하였다. YEPD 브로스에서 성장시킨 형질전환체의 플라스미드 안정성은 106 희석된 3일간 배양된 배양물의 현탁액 200 ㎕를 ura- 선택 플레이트 및 비선택성 YEPD 플레이트에 플레이팅하여 측정한 결과, 65% 이상의 세포가 3일 정치배양 후에 플라스미드를 소실함이 확인되었다(표 1). ura- 선택 배지에서 배양된 세포에서도, YEPD 배지만큼 높지는 않았으나, 높은 플라스미드 불안정성이 나타났으며, 플레이팅된 세포의 50%가 별개의 콜로니를 형성할 수 없었다.CFU was measured in nonselective YEPD medium as well as selection medium, and plasmid stability and cell growth were confirmed by counting the number of cells using a hematocytometer. Plasmid stability was confirmed for transformants TYEGLAC3-1 and two randomly selected transformants TYEGLAC3-5 and -7. Plasmid stability of transformants grown on YEPD broth was measured by plating 200 μl of a suspension of cultured for 10 days diluted on 6 6 dilution in ura - selective plates and non-selective YEPD plates, resulting in at least 65% of cells being cultured for 3 days It was confirmed that the plasmid was lost after the incubation (Table 1). Even in cells cultured in ura - selection medium, although not as high as YEPD medium, high plasmid instability appeared, and 50% of the plated cells could not form separate colonies.
lac3 형질전환체와 모방 형질전환체의 세포 성장을 비교하였다. YEPD 플레이트에서 917 CFU를 보이는 모방 형질전환체에 비해, lac3 형질전환체는 40% 이하의 성장을 보였다. 또한, 세포가 ura- 선택 브로스에서 배양된 경우, 더 많은 세포 성장의 감소(≥25%)가 관찰되었다(표 1).
Cell growth of lac3 and mimic transformants was compared. Compared to mimic transformants showing 917 CFU on YEPD plates, lac3 transformants showed up to 40% growth. In addition, the cells are ura - was observed when the culturing in selection broth, more cells reduction (≥25%) of the growth (Table 1).
2-4. 발현된 LAC3에 대한 배양된 브로스의 영향2-4. Effect of Cultured Broth on Expressed LAC3
비선택성 YEPD 배지에서 TYEGLAC3-1 형질전환체를 배양하는 동안 플라스미드를 포함하는 세포의 수는 현저하게 감소하지만, 여전히 상당수의 세포가 플라스미드를 포함하고 있었다. 이에, YEPD의 배양물 상층액에서 라카제 활성이 검출되지 않는 이유를 확인하고자 하였다. 이를 위해, 라카제 활성을 포함하는 ura- 선택 브로스의 상층액을 YEPD의 배양물 상층액과 혼합한 후 효소의 활성을 측정하였다. 25℃에서 24시간 정치배양한 후 라카제 활성이 나타나지 않았다. 그러나, 신선한 YEPD 배지 또는 반응 완충액과의 혼합은 라카제 활성을 보여, 발현된 라카제 활성이 배양된 YEPD 배지에 민감한 반면, ura- 선택 배지에서 라카제 활성이 안정적으로 유지됨을 알 수 있었다.While incubating TYEGLAC3-1 transformants in non-selective YEPD medium, the number of cells containing plasmids decreased significantly, but still a significant number of cells contained plasmids. Thus, we tried to determine why laccase activity was not detected in the culture supernatant of YEPD. To this end, the supernatant of ura - selective broth containing laccase activity was mixed with the culture supernatant of YEPD and the enzyme activity was measured. After stationary culture at 25 ° C. for 24 hours, no laccase activity was observed. However, mixing with fresh YEPD medium or reaction buffer showed laccase activity, indicating that the expressed laccase activity was sensitive to the cultured YEPD medium, while the laccase activity remained stable in ura - selective medium.
배양된 YEPD 배지에서 발현된 라카제 활성의 불안정성은 다양한 프로테아제 억제제를 이용하여 확인되었다. 도 5에 나타낸 바와 같이, ura- 선택 브로스의 상층액에 있는 라카제 활성은 이 배지가 배양된 YEPD 브로스의 상층액과 혼합되었을 때 상쇄되었다. 배양된 YEPD 배지가 아스파르틸 프로테아제 억제제인 펩스타틴과 전정치배양된 후 라카제 활성을 포함하는 ura- 선택성 브로스의 상층액과 혼합되었을 때 잔류 라카제 활성이 관찰되었으다. 아프로티닌, EDTA, E-64 프로테아제 억제제, 루펩틴 또는 PMSF에서는 어떠한 보호도 확인되지 않았다.
Instability of laccase activity expressed in cultured YEPD media was confirmed using various protease inhibitors. As shown in Figure 5, ura - lacquer activity in the supernatant of the selection broth was offset when mixed with the supernatant of the cultured medium it is YEPD broth. Residual laccase activity was observed when the cultured YEPD medium was mixed with supernatant of ura - selective broth containing laccase activity after prepolitical incubation with pepstatin, an aspartyl protease inhibitor. No protection was identified with aprotinin, EDTA, E-64 protease inhibitors, lupetin or PMSF.
2-5. 유도성 GAL1 프로모터를 이용한 LAC3 단백질의 발현2-5. Expression of LAC3 Protein Using Inducible GAL1 Promoter
유도성 GAL1 프로모터에 의한 라카제 3을 코딩하는 트랜스 유전자의 발현이 확인되었다. 플라스미드 pYEGALLAC3을 포함하는 형질전환체를 2% 갈락토오스를 포함하는 유도 배지에서 5일 동안 배양한 결과, 모든 형질전환체의 배양물 상층액에서 효소 활성이 확인되었다(도 2c). 일차 접종액은 선택성을 유지하되 탄소원으로 2% 라피노스/0.1% 글루코스를 포함하는 배지 5ml로부터 준비되었다. 가장 높은 효소 활성으로 41.5mU/ml 배양물 상층액을 보인 형질전환체 TYEGALLAC3-6이 후속 실시예에 이용되었다. 구성성 GPD 프로모터에 의해 lac3를 발현하는 형질전환체 TYEGALLAC3-1 보다는 유도성 GAL1 프로모터를 이용하는 형질전환체가 더 높은 라카제 활성을 보였다. YEPD 배지에서 TYEGALLAC3-6 형질전환체의 성장이 감소되지 않아(표 2), 라카제 발현이 일어나지 않는 한, 성장은 감소하지 않음을 보여주었다. 선택된 TYEGALLAC3-6로 플라스미드(pYEGALLAC3-6)의 도입 안정성도 우수하여 세포의 85% 이상이 비선택성 배지에서 3일 동안 정치배양 후에 플라스미드를 보유하였다. 이러한 결과는 플라스미드의 안정성이 라카제 발현이 유도되지 않는 한 유지됨을 의미한다.
Expression of the trans
실시예 3: 라카제 3의 염색약 탈색 효과 검증Example 3: Validation of the dye bleaching effect of
마이크로플레이트에 에이시드 블루 147(Acid blue 147), 쿠사미 브릴리언트 블루 G250(Coomassie brilliant blue G250), 크리스탈 바이올렛(Crystal violet), 메틸렌 블루(Methylene blue), 브릴리언트 블루 R(Brilliant blue R), 말라카이트 그린 G(Malacite Green G), 레마졸 브릴리언트 블루 R(Remazol brilliant blue R), 말라카이트 그린 베이스(Malachite Green base)를 분주한 후 ura- 결핍 배지(음성 대조군), lac3 발현 형질전환체의 배양액(약10~20mU), 트라메티스 베리콜로(Trametes vericolor) 균주의 라카제(대조군 1mU 또는 10mU)를 각각 넣어 정치배양한 후 상기 염색약들의 탈색 효과를 관찰하였다. 그 결과, 본 발명의 라카제 3이 말라카이트 그린 G를 탈색할 수 있음을 확인하였다.Acid blue 147, Coomassie brilliant blue G250, Crystal violet, Methylene blue, Brilliant blue R, Malachite green on microplates After dispensing G (Malacite Green G), Remazol brilliant blue R, and Malachite Green base, cultures of ura - deficient medium (negative control) and lac3 expressing transformants (about 10 ~ 20mU), Lameze (Trametes vericolor) strain of Lacase (control 1mU or 10mU) was put in each of the stationary culture and observed for the bleaching effect of the dyes. As a result, it was confirmed that
<110> INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY <120> Tannic acid-degradable laccase 3 of Cryphonectria parasitica and usage thereof <160> 7 <170> KopatentIn 1.71 <210> 1 <211> 26 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 1 ggtctagaat gcaggtgctg aacacc 26 <210> 2 <211> 27 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 2 ggtctagatt atatgcccga atcgtcc 27 <210> 3 <211> 30 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 3 aacttgacag ccggggctcc cagtgtcgag 30 <210> 4 <211> 30 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 4 ctcgacactg ggagccccgg ctgtcaagtt 30 <210> 5 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 5 gcagctcgag ctcgaggaca acagc 25 <210> 6 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 6 cccaagcttt tatatgcccg a 21 <210> 7 <211> 567 <212> PRT <213> Cryphonectria parasitica <400> 7 Met Ala Leu Arg Ala Phe Leu Ser Leu Leu Pro Ala Leu Ser Leu Val 1 5 10 15 Thr Ala Ala Pro Ser Val Glu Pro Tyr Gln Leu Ser Lys Arg Cys Val 20 25 30 Asn Ser Ala Asp Asp Arg Ser Cys Trp Gly Asp Tyr Asp Leu Ser Thr 35 40 45 Asn Tyr Tyr Asp Glu Ala Pro Phe Thr Asn Val Thr Arg Glu Tyr Trp 50 55 60 Phe Asn Ile Val Asn Thr Thr Ala Ser Pro Asp Gly Val Glu Lys Ile 65 70 75 80 Val Leu Ala Val Asn Gly Ser Ile Pro Gly Pro Thr Ile Val Ala Asp 85 90 95 Trp Gly Asp Thr Val Val Val His Val Thr Asn Ser Met Gln Asn Asn 100 105 110 Gly Ser Ser Ile His Phe His Gly Ile Arg Gln Asn Phe Thr Asn Gln 115 120 125 Asn Asp Gly Val Ala Ser Ile Thr Gln Cys Pro Thr Ala Pro Gly Asp 130 135 140 Thr Thr Thr Tyr Thr Trp Arg Ala Leu Gln Tyr Gly Thr Ser Trp Trp 145 150 155 160 His Ser His Phe Tyr Val Gln Ala Trp Asp Gly Val Tyr Gly Gly Ile 165 170 175 Gln Ile Asn Gly Pro Ala Thr Ala Asn Tyr Asp Glu Asp Leu Gly Val 180 185 190 Val Ser Met Met Asp Trp Asp His Asp Thr Ala Asp Asn Leu Val Leu 195 200 205 Gln Ser Ala Val Thr Gly Pro Pro Thr Met Ala Asn Gly Leu Ile Asn 210 215 220 Gly Met Asn Val Tyr Thr Leu Glu Asp Asn Ser Thr Val Gly Ser Arg 225 230 235 240 Tyr Glu Met Glu Phe Thr Ser Gly Gln Arg Tyr Arg Leu Arg Leu Val 245 250 255 Asn Thr Ala Ala Asp Thr His Phe Lys Phe Thr Ile Asp Asn His Thr 260 265 270 Met Glu Val Ile Ala Ser Asp Phe Val Pro Ile Gln Pro Tyr Thr Thr 275 280 285 Asp Val Val Asn Ile Gly Ile Gly Gln Arg Tyr Asp Val Ile Val Thr 290 295 300 Ala Asp Ala Pro Ser Asp Asn Tyr Trp Met Arg Ala Ile Ala Gln Leu 305 310 315 320 Ala Cys Ser Asp Asn Asp Asn Pro Asp Asn Ile Lys Ala Ile Ile Arg 325 330 335 Tyr Ser Asp Ala Ala Asn Ser Thr Ala Asp Pro Thr Ser Thr Ala Thr 340 345 350 Ala Asp Ala Ser Val Asp Glu Cys Val Asp Glu Pro Ala Ala Ser Leu 355 360 365 Val Pro Tyr Leu Ala Ile Pro Ala Gly Gly Ser Ala Asp Val Thr Asp 370 375 380 Asn Phe Ala Val Ala Val Glu Gln Leu Ala Gly Arg Val Asp Trp Ala 385 390 395 400 Met Gly Asn Thr Thr Phe Ile Asn Glu Trp Gly Tyr Pro Ser Ile Gln 405 410 415 Gln Val Tyr Asp Gly Asn Asn Thr Trp Gly Glu Ser Gln Asn Val Ile 420 425 430 Gln Leu Pro Gln Ala Asn Glu Trp Val Tyr Trp Ile Val Gln Thr Thr 435 440 445 Met Gly Val Thr His Pro Met His Met His Gly His Asp Phe Trp Val 450 455 460 Leu Gly Ala Gly Thr Gly Thr Phe Asp Ser Ala Thr Ala Ser Leu Ser 465 470 475 480 Thr Val Asn Val Pro Arg Arg Asp Val Thr Met Leu Pro Ala Ser Gly 485 490 495 Trp Thr Val Ile Ala Phe Ile Thr Asp Asn Pro Gly Val Trp Leu Thr 500 505 510 His Cys His Ile Ala Trp His Thr Ser Glu Gly Leu Ala Val Gln Met 515 520 525 Val Glu Arg Glu Ser Glu Ile Val Asp Leu Ile Asp Ala Asp Leu Met 530 535 540 Asn Ser Thr Cys Gly Ala Trp Asn Asp Tyr Ala Asn Lys Val Ala Leu 545 550 555 560 Val Gln Asp Asp Ser Gly Ile 565 <110> INDUSTRIAL COOPERATION FOUNDATION CHONBUK NATIONAL UNIVERSITY <120> Tannic acid-degradable laccase 3 of Cryphonectria parasitica and usage <160> 7 <170> KopatentIn 1.71 <210> 1 <211> 26 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 1 ggtctagaat gcaggtgctg aacacc 26 <210> 2 <211> 27 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 2 ggtctagatt atatgcccga atcgtcc 27 <210> 3 <211> 30 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 3 aacttgacag ccggggctcc cagtgtcgag 30 <210> 4 <211> 30 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 4 ctcgacactg ggagccccgg ctgtcaagtt 30 <210> 5 <211> 25 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 5 gcagctcgag ctcgaggaca acagc 25 <210> 6 <211> 21 <212> DNA <213> Artificial Sequence <220> <223> primer <400> 6 cccaagcttt tatatgcccg a 21 <210> 7 <211> 567 <212> PRT <213> Cryphonectria parasitica <400> 7 Met Ala Leu Arg Ala Phe Leu Ser Leu Leu Pro Ala Leu Ser Leu Val 1 5 10 15 Thr Ala Ala Pro Ser Val Glu Pro Tyr Gln Leu Ser Lys Arg Cys Val 20 25 30 Asn Ser Ala Asp Asp Arg Ser Cys Trp Gly Asp Tyr Asp Leu Ser Thr 35 40 45 Asn Tyr Tyr Asp Glu Ala Pro Phe Thr Asn Val Thr Arg Glu Tyr Trp 50 55 60 Phe Asn Ile Val Asn Thr Thr Ala Ser Pro Asp Gly Val Glu Lys Ile 65 70 75 80 Val Leu Ala Val Asn Gly Ser Ile Pro Gly Pro Thr Ile Val Ala Asp 85 90 95 Trp Gly Asp Thr Val Val Val His Val Thr Asn Ser Met Gln Asn Asn 100 105 110 Gly Ser Ser Ile His Phe His Gly Ile Arg Gln Asn Phe Thr Asn Gln 115 120 125 Asn Asp Gly Val Ala Ser Ile Thr Gln Cys Pro Thr Ala Pro Gly Asp 130 135 140 Thr Thr Thr Tyr Thr Trp Arg Ala Leu Gln Tyr Gly Thr Ser Trp Trp 145 150 155 160 His Ser His Phe Tyr Val Gln Ala Trp Asp Gly Val Tyr Gly Gly Ile 165 170 175 Gln Ile Asn Gly Pro Ala Thr Ala Asn Tyr Asp Glu Asp Leu Gly Val 180 185 190 Val Ser Met Met Asp Trp Asp His Asp Thr Ala Asp Asn Leu Val Leu 195 200 205 Gln Ser Ala Val Thr Gly Pro Pro Thr Met Ala Asn Gly Leu Ile Asn 210 215 220 Gly Met Asn Val Tyr Thr Leu Glu Asp Asn Ser Thr Val Gly Ser Arg 225 230 235 240 Tyr Glu Met Glu Phe Thr Ser Gly Gln Arg Tyr Arg Leu Arg Leu Val 245 250 255 Asn Thr Ala Ala Asp Thr His Phe Lys Phe Thr Ile Asp Asn His Thr 260 265 270 Met Glu Val Ile Ala Ser Asp Phe Val Pro Ile Gln Pro Tyr Thr Thr 275 280 285 Asp Val Val Asn Ile Gly Ile Gly Gln Arg Tyr Asp Val Ile Val Thr 290 295 300 Ala Asp Ala Pro Ser Asp Asn Tyr Trp Met Arg Ala Ile Ala Gln Leu 305 310 315 320 Ala Cys Ser Asp Asn Asp Asn Pro Asp Asn Ile Lys Ala Ile Ile Arg 325 330 335 Tyr Ser Asp Ala Ala Asn Ser Thr Ala Asp Pro Thr Ser Thr Ala Thr 340 345 350 Ala Asp Ala Ser Val Asp Glu Cys Val Asp Glu Pro Ala Ala Ser Leu 355 360 365 Val Pro Tyr Leu Ala Ile Pro Ala Gly Gly Ser Ala Asp Val Thr Asp 370 375 380 Asn Phe Ala Val Ala Val Glu Gln Leu Ala Gly Arg Val Asp Trp Ala 385 390 395 400 Met Gly Asn Thr Thr Phe Ile Asn Glu Trp Gly Tyr Pro Ser Ile Gln 405 410 415 Gln Val Tyr Asp Gly Asn Asn Thr Trp Gly Glu Ser Gln Asn Val Ile 420 425 430 Gln Leu Pro Gln Ala Asn Glu Trp Val Tyr Trp Ile Val Gln Thr Thr 435 440 445 Met Gly Val Thr His Pro Met His Met His Gly His Asp Phe Trp Val 450 455 460 Leu Gly Ala Gly Thr Gly Thr Phe Asp Ser Ala Thr Ala Ser Leu Ser 465 470 475 480 Thr Val Asn Val Pro Arg Arg Asp Val Thr Met Leu Pro Ala Ser Gly 485 490 495 Trp Thr Val Ile Ala Phe Ile Thr Asp Asn Pro Gly Val Trp Leu Thr 500 505 510 His Cys His Ile Ala Trp His Thr Ser Glu Gly Leu Ala Val Gln Met 515 520 525 Val Glu Arg Glu Ser Glu Ile Val Asp Leu Ile Asp Ala Asp Leu Met 530 535 540 Asn Ser Thr Cys Gly Ala Trp Asn Asp Tyr Ala Asn Lys Val Ala Leu 545 550 555 560 Val Gln Asp Asp Ser Gly Ile 565
Claims (20)
서열번호 : 7에 나타낸 아미노산 서열로 이루어지는 것을 특징으로 하는 라카제 3.The method of claim 1,
Lacase 3, consisting of the amino acid sequence shown in SEQ ID NO: 7.
상기 라카제 3의 코딩 영역은 성숙형 라카제 3의 코딩 영역인 것을 특징으로 하는 재조합 발현 벡터.The method of claim 3,
The coding region of Lacase 3 is a recombinant expression vector, characterized in that the coding region of mature Lacase 3.
상기 라카제 3의 코딩 영역은 유도성 프로모터의 조절을 받는 것을 특징으로 하는 재조합 발현 벡터.The method of claim 3,
The coding region of Lacase 3 is recombinant expression vector, characterized in that under the control of the inducible promoter.
상기 유도성 프로모터는 GAL1(galactose kinase) 프로모터인 것을 특징으로 하는 재조합 발현 벡터.6. The method of claim 5,
The inducible promoter is a recombinant expression vector, characterized in that the GAL1 (galactose kinase) promoter.
상기 라카제 3의 코딩 영역은 벼 유래의 아밀라제 1A(Ramy1A)의 시그널 펩타이드와 작동 가능하게 연결된 것을 특징으로 하는 재조합 발현 벡터.The method of claim 3,
The coding region of Lacase 3 is recombinant expression vector, characterized in that it is operatively connected with a signal peptide of amylase 1A ( Ramy 1A) derived from rice.
상기 재조합 발현 벡터는 도 1a에 나타낸 개열 지도를 가지는 pYEGLAC3 또는 도 1b에 나타낸 개열 지도를 가지는 pYEGALLAC3인 것을 특징으로 하는 재조합 발현 벡터.The method of claim 3,
The recombinant expression vector is pYEGLAC3 having a cleavage map shown in Figure 1a or pYEGALLAC3 having a cleavage map shown in Figure 1b.
상기 효모는 사카로미세스 속인 것을 특징으로 하는 숙주세포.The method of claim 9,
The yeast is a host cell, characterized in that the genus Saccharomyces.
상기 사카로미세스 속은 사카로미세스 세레비시애인 것을 특징으로 하는 숙주세포.The method of claim 10,
The genus Saccharomyces is a host cell, characterized in that Saccharomyces cerevisiae.
상기 우라실 결핍 배지는 아미노산이 포함되지 않은 효모 질소 베이스(yeast nitrogen base without amino acids), 아데닌, 트립토판, 카사미노산(casamino acid), 덱스트로스를 포함하는 것을 특징으로 하는 제조방법.The method of claim 12,
The uracil deficient medium comprises a yeast nitrogen base without amino acids, adenine, tryptophan, casamino acid, and dextrose.
상기 우라실 결핍 배지는 5~8 g/l 아미노산이 포함되지 않은 효모 질소 베이스, 0.01~0.05 g/l 아데닌, 0.01~0.05 g/l 트립토판, 3~9 g/l 카사미노산, 15~25 g/l 덱스트로스를 포함하는 것을 특징으로 하는 제조방법.The method of claim 13,
The uracil deficient medium is a yeast nitrogen base not containing 5-8 g / l amino acid, 0.01-0.05 g / l adenine, 0.01-0.05 g / l tryptophan, 3-9 g / l casamino acid, 15-25 g / l l Production method characterized in that it comprises dextrose.
라카제 3이 발현되는 상태인 경우 1 내지 5일 동안 배양하는 것을 특징으로 하는 제조방법.The method of claim 12,
If Lacase 3 is expressed in the manufacturing method, characterized in that culture for 1 to 5 days.
상기 라카제 3은 탄닌산을 분해하는 효소 활성을 보유하는 것을 특징으로 하는 제조방법.The method of claim 2,
Lacase 3 has an enzyme activity that decomposes tannic acid.
상기 염색약은 말라카이트 그린 G인 것을 특징으로 하는 조성물.19. The method of claim 18,
The dye is malachite green G, characterized in that the composition.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100076936A KR101309061B1 (en) | 2010-08-10 | 2010-08-10 | Tannic acid-degradable laccase 3 of Cryphonectria parasitica and usage thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR1020100076936A KR101309061B1 (en) | 2010-08-10 | 2010-08-10 | Tannic acid-degradable laccase 3 of Cryphonectria parasitica and usage thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
KR20120014766A true KR20120014766A (en) | 2012-02-20 |
KR101309061B1 KR101309061B1 (en) | 2013-10-15 |
Family
ID=45837724
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
KR1020100076936A KR101309061B1 (en) | 2010-08-10 | 2010-08-10 | Tannic acid-degradable laccase 3 of Cryphonectria parasitica and usage thereof |
Country Status (1)
Country | Link |
---|---|
KR (1) | KR101309061B1 (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113430181A (en) * | 2021-08-09 | 2021-09-24 | 云南师范大学 | Bacterial laccase derived from Asian elephant intestinal metagenome and gene thereof |
-
2010
- 2010-08-10 KR KR1020100076936A patent/KR101309061B1/en active IP Right Grant
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113430181A (en) * | 2021-08-09 | 2021-09-24 | 云南师范大学 | Bacterial laccase derived from Asian elephant intestinal metagenome and gene thereof |
Also Published As
Publication number | Publication date |
---|---|
KR101309061B1 (en) | 2013-10-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Record et al. | Expression of the Pycnoporus cinnabarinus laccase gene in Aspergillus niger and characterization of the recombinant enzyme | |
Liu et al. | Molecular cloning and characterization of a laccase gene from the basidiomycete Fome lignosus and expression in Pichia pastoris | |
Antošová et al. | Yeast hosts for the production of recombinant laccases: a review | |
Jolivalt et al. | Expression of laccase IIIb from the white-rot fungus Trametes versicolor in the yeast Yarrowia lipolytica for environmental applications | |
Ko et al. | Purification and characterization of laccase isozymes from the white-rot basidiomycete Ganoderma lucidum | |
Yaver et al. | Purification, characterization, molecular cloning, and expression of two laccase genes from the white rot basidiomycete Trametes villosa | |
Sun et al. | Secretory expression and characterization of a soluble laccase from the Ganoderma lucidum strain 7071-9 in Pichia pastoris | |
Klonowska et al. | LAC3, a new low redox potential laccase from Trametes sp. strain C30 obtained as a recombinant protein in yeast | |
You et al. | Molecular cloning of a laccase gene from Ganoderma lucidum and heterologous expression in Pichia pastoris | |
Ma et al. | High-level expression of a bacterial laccase, CueO from Escherichia coli K12 in Pichia pastoris GS115 and its application on the decolorization of synthetic dyes | |
JPH09503126A (en) | Purification ▲ pH ▼ Neutral Rhizoctonia laccase and nucleic acid encoding the same | |
Mate et al. | Switching from blue to yellow: altering the spectral properties of a high redox potential laccase by directed evolution | |
CN108239648B (en) | Method for efficiently expressing rhizomucor miehei lipase | |
TWI410492B (en) | Novel fungal laccases and uses thereof | |
Kim et al. | Heterologous expression of a tannic acid-inducible laccase3 of Cryphonectria parasitica in Saccharomyces cerevisiae | |
Kim et al. | Optimization of the functional expression of Coprinus cinereus peroxidase in Pichia pastoris by varying the host and promoter | |
KR20130100108A (en) | Filamentous fungi having an altered viscosity phenotype | |
US8609386B2 (en) | Polypeptides having tyrosinase activity and polynucleotides encoding same | |
Yano et al. | Secretory expression of the non-secretory-type Lentinula edodes laccase by Aspergillus oryzae | |
Bo et al. | Heterologous expression and characterization of a laccase from Laccaria bicolor in Pichia pastoris and Arabidopsis thaliana | |
KR101309061B1 (en) | Tannic acid-degradable laccase 3 of Cryphonectria parasitica and usage thereof | |
CA2103522C (en) | Yeast host strains with defects in n-glycosylation | |
JP4309681B2 (en) | Preparation method of Shiitake laccase and degradation method of phenolic environmental pollutants | |
AU725639B2 (en) | DNA sequences, expression of these DNA sequences, thermophilic laccases encoded by the DNA sequences, and the use thereof | |
Kim et al. | Evaluation of copper-inducible fungal laccase promoter in foreign gene expression in Pichia pastoris |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A201 | Request for examination | ||
E902 | Notification of reason for refusal | ||
E902 | Notification of reason for refusal | ||
E701 | Decision to grant or registration of patent right | ||
GRNT | Written decision to grant | ||
FPAY | Annual fee payment |
Payment date: 20160825 Year of fee payment: 4 |
|
FPAY | Annual fee payment |
Payment date: 20170829 Year of fee payment: 5 |